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The negative symptoms of psychosis and depressive symptomatology share several features 
e.g. low motivation, apathy and reduced activity. Understanding the links between these two 
sets of symptoms will inform the development of future interventions targeting these 
difficulties in people with psychosis. The aim of this systematic review and meta-analysis is to 
quantify the relationship between these two clusters of symptoms, as measured in studies to 
date. Further analyses investigate potential moderating variables. PsycInfo, Embase and 
Medline were systematically searched to identify eligible studies. Inclusion criteria measured 
both depression and negative symptoms using validated measures in a sample with non-
affective psychosis diagnoses. 2020 records were initially screened and 56 were included in the 
meta-analysis and review. Both meta-analyses and meta-regressions were conducted to 
explore the main effect and potential moderating variables. The findings showed a significant 
but small relationship between negative and depressive symptoms (Effect Size = 0.19). This did 
not vary greatly with the measures used and was not moderated by demographic variables or 
quality ratings. Depression and negative symptom severity showed an inverse reciprocal 
relationship. Heterogeneity was high across these analyses. The findings show that there is a 
relationship between depression and negative symptoms in people with psychosis. This is 












The negative symptoms of psychosis include low motivation, anhedonia, alogia, social 
withdrawal and blunted affect (Kirkpatrick, Fenton, Carpenter, & Marder, 2006). Research has 
shown that these symptoms have a significant impact on functioning (Menendez-Miranda et 
al., 2015; Robertson et al., 2014; Rocca et al., 2014), with some studies suggesting these 
difficulties are a bigger barrier to recovery than positive or cognitive symptoms (Berenbaum, 
Kerns, Vernon, & Gomez, 2008; Marchesi et al., 2015). Negative symptoms were initially 
conceptualised as primary, a core feature of the illness, or secondary – present due to other 
factors such as substance misuse, medication side-effects, depression or as a response to the 
positive symptoms (Peralta, Cuesta Mj Fau - Martinez-Larrea, Martinez-Larrea A Fau - Serrano, 
& Serrano, 2000). However this distinction has been found to have limited clinical reliability 
and utility (Kirschner 2016; Peralta 2000) and more recent research has focused on a 
distinction within negative symptoms – experiential vs. expressive (Messinger et al., 2011). 
Experiential symptoms include low motivation, anhedonia and withdrawal whereas expressive 
symptoms are identified as blunted affect and alogia. Depression also includes a range of 
symptoms with similarities to negative symptoms, and the following are highlighted as key in 
the diagnostic criteria: loss of pleasure (anhedonia), low motivation and low mood (American 
Psychiatric Association, 2013). A narrative review of the literature concluded that depressive 
symptoms are very common in people with schizophrenia and perhaps up to 50% of people 
with this diagnosis would also meet criteria for depression (Buckley, Miller, Lehrer, & Castle, 
2009; Siris, 2003). This review by Buckley et al. (2009) also found that co-morbid depressive 







One conceptualisation of these difficulties is that depression is a separate disorder co-morbid 
with psychosis, including negative symptoms. The underlying idea behind this is that both 
depressive and negative symptoms are driven by different organic processes (Malaspina et al., 
2014). Some attempt has also been made to identify people for whom low mood is a significant 
problem alongside psychosis and this has resulted in diagnoses such as “schizoaffective 
disorder”, “depression with psychotic features” and also applies of course to bipolar disorder. 
The usefulness of these diagnostic labels in clinical practice, particularly schizoaffective 
disorder, is still debated in the field (Siris, 2003). Kirschner, Aleman, and Kaiser (2016) 
concluded in their narrative review that the presence of depressive symptoms in someone with 
psychosis may be missed because of the lack of clarity regarding how to reliably assess them. 
This may negatively impact on their treatment options as evidence-based treatments for 
depression are not offered to these individuals. It could also be argued that the 
conceptualisation of these difficulties as organically-driven has limited the development of 
psychological models and treatments in this field.  
 
Alternative conceptualisations of depressive symptoms are either as one dimension of negative 
symptoms or as part of the wider psychosis spectrum, driven by psychological processes as 
described in a review by Sarkar, Hillner, and Velligan (2015). Indeed, psychological models of 
psychosis e.g. Garety, Kuipers, Fowler, Freeman, and Bebbington (2001) have proposed a direct 
route from emotional changes to experiences of psychotic symptoms.  The phenomenological 
overlap between negative and depressive symptoms is more apparent with experiential 
negative symptoms which include low motivation and anhedonia, commonly seen in 






include specific subscales of experiential symptoms and there is some evidence that they show 
good divergent validity from depressive measures (Forbes et al., 2010; Llerena et al., 2013). 
This has been achieved by focusing on low motivation across several areas of functioning 
(social, employment, hobbies) rather than using terms such as “low energy” or “low mood” 
which can measure depressive symptoms. Experiential subscales do not assess cognitive 
symptoms and there is some indication in the literature that this may be where distinctions can 
also be drawn from depressive symptoms although findings are mixed (Kirkpatrick, 2014). 
Hopelessness, guilt and suicidal ideation are reliably indicated as important cognitions in 
depression, whereas self-defeatist beliefs appear to play a role in negative symptoms and have 
been incorporated into the cognitive model of negative symptoms developed by Grant and 
Beck (2009). Thus, the areas of overlap between negative and depressive symptoms and the 
psychological processes that may underlie these are still unclear, limiting the ability to develop 
targeted treatments for these difficulties.  
 
The evidence regarding the overlap between these symptoms has been mixed with some 
studies finding an association between depressive symptoms and negative symptoms and 
others reporting none (Amr & Volpe, 2013; Blanchard, Horan, & Brown, 2001; Edwards, Cella, 
Tarrier, & Wykes, 2015a; Pelizza & Ferrari, 2009). This variation in findings may be due to the 
range of measures used to assess both depression and negative symptoms in people with 
psychosis. In a systematic review which examined the psychometric properties of measures of 
depression in schizophrenia, Lako et al. (2012) concluded that the Calgary Depression Scale for 
Schizophrenia (CDSS) has the best divergent validity in that it reliably distinguishes depressive 
symptoms from negative symptoms. Lako et al. (2012) propose that this difference is because 






interest” was excluded because it is a feature of both negative symptoms and depression. 
However, this deliberate goal of minimising overlap might lead to poor identification of certain 
valid experiences. The performance of other negative symptoms measures in terms of 
divergent validity from depression measures, or identifying areas of overlap, is not clear among 
these mixed findings. A recent systematic review (Krynicki, Upthegrove, Deakin, & Barnes, 
2018) considered the relationship between depressive and negative symptoms in people with a 
diagnosis of schizophrenia and concluded that the symptom domains of pessimism, low mood 
and suicidal ideation may be specific to depression, while alogia and blunted affect are specific 
to negative symptoms. However, they also concluded the domains of anhedonia, avolition and 
anergia may be common to both and used this to suggest a dimensional model of negative, 
positive and depressive symptoms. Since this model is based on narrative evidence and the 
findings regarding these proposed relationships are mixed, a quantitative synthesis of the 
evidence would be valuable to develop our understanding further.  
 
The time is therefore ripe for a systematic meta-analysis of this field to progress both the 
assessment and treatment of negative and depressive symptoms in psychosis. This method 
improves on previous systematic reviews by quantifying this relationship and will include 
studies which have assessed both negative and depressive symptoms. Finally, this meta-
analysis was the first to look at the sub-domains of negative symptoms which are reflected in 
newer measures and may help clarify the process of assessment for clinicians. If it is shown 
that there is a significant relationship, then this may suggest new conceptualisations and 








The following research questions were addressed in this review and meta-analysis: 
1. Is there a relationship between negative symptoms and depression in people with 
psychosis? 
2. Does this relationship vary according to depression or negative symptom measures 
or subscales used? 
3. Is this relationship moderated by depressive or negative symptom severity? 
4. Is this relationship moderated by the diagnosis of the sample, quality of the study 
or demographic factors? 
Method  
Inclusion criteria  
Studies were included if they (i) include a population with at least one of the diagnoses 
in the group of non-affective psychotic disorders (ii) include a validated measure of negative 
symptoms in psychosis (iii)  include a validated measure of depression in psychosis (iv) have 
been published in a peer-reviewed publication (v)  have been written in English. Studies were 
included if the results reported a test of a direct association between the negative symptom 
measure and depression measure regardless of whether this was the primary outcome of the 
study.  
 
Exclusion criteria  
Studies were excluded if they were (i) conference abstracts (ii) book chapters (iii) 
theoretical or review articles (iv) qualitative data only was presented or (v) they were single 
case studies or dissertations. Studies were also excluded if the sample included people with a 






primary in these diagnoses. Studies were excluded if they removed people who met criteria for 
depression from their sample as we wished to analyse the relationship at all levels of 
depressive symptoms. Studies which only used a single item to assess depressive symptoms 
were excluded as this was not considered robust enough. Negative symptoms were also often 
assessed using the same scale e.g. Positive and Negative Syndrome Scale (PANSS) which 
included this single depression item raising concerns about co-variance. Studies were also 
excluded if insufficient statistical information was provided for the paper to be included in the 
analyses e.g. only associations for change scores presented or authors did not respond to 
request for additional data (k = 3).  
 
Literature search 
PROSPERO was examined for reviews with an overlapping research question, none 
were identified. This review was then registered on the PROSPERO database (ID: 
CRD42017083440). Relevant studies were identified through the systematic search of the 
databases Medline, Embase and PsycINFO. These databases were selected to fully capture the 
range of journals in this field. The following search terms were used as heading or keyword 
searches: (SCHIZOPHREN* OR SCHIZOAFFECT OR PSYCHOSIS OR PSYCHOTIC) AND (NEGATIVE 
SYMPTOMS) AND (DEPRESS*). The use of search terms targeting specific depressive or 
negative symptoms (e.g. anergia, alogia, motivation) were considered but not included as the 
focus of this review is on the whole range of depressive and negative symptomatology and 
including individual symptoms may have biased the sample of papers identified. A recent 
narrative review (Krynicki et al., 2018) which did include individual symptoms returned a 








The current review followed the flow of information as suggested by the PRISMA statement 
(Moher, Liberati, Tetzlaff, & Altman, 2009). Following the initial search, duplicate records were 
removed, and the inclusion and exclusion criteria were applied.    
 
Quality assessment  
 Studies were assessed using an adapted version of the Quality Assessment Tool for 
Quantitative Studies (Thomas, Dobbins, Fau, & Micucci, 2004); see Appendix for rating scale 
and instructions. The measure was adapted by removing sections C, D and G which were 
relevant for randomised controlled trials only and therefore not for the studies included in this 
meta-analysis. One additional item was added which assessed whether the analyses of 
negative and depressive symptoms was outlined in the design of the study or whether it was 
the result of secondary analyses. This was felt to be an important quality criterion in this group 
of studies. All studies were rated by CE and a sample of 10% (k = 6) were rated by an 
independent assessor. One of these six papers had a discrepancy greater than 2 between 
raters, this rating was discussed – it was specifically discrepant on the selection bias item only, 
and a consensus reached. The ratings were shown to have excellent reliability (Intraclass 
Correlation = .94, 95% CIs = .76 - .99).  
 
Data extraction and analytic procedure  
 Based on the inclusion criteria, 56 studies were considered eligible for inclusion in the 
final meta-analyses. The following data were extracted from each study: sample size, age, 
gender, ethnicity, diagnosis (% schizoaffective disorder), mean scores on depression and 






was weighted appropriately where multiple Pearson’s r values were presented for different 
subscales these were combined for the main analysis. Individual subscales were reported in 
sub-group analyses. All scores were converted to Fisher’s z scores to represent the continuous 
nature of the data and to minimise the risk of bias associated with Pearson’s r (Borenstein, 
Hedges, Higgins, & Rothstein, 2009). All analyses were conducted in Stata (StataCorp, 2017) 
using the metan package for meta-analyses and metareg for meta-regressions. We 
hypothesised that the true effect sizes would vary with sample variations acting as moderating 
variables, and so random effect models were chosen for the meta-analyses of main effects as 
well as meta-regressions and subgroup analyses (Borenstein, Hedges, Higgins, & Rothstein, 
2010). The main analysis was conducted to assess the relationship between depressive and 
negative symptoms and included all the studies. Sub-group analyses were conducted to 
examine this relationship when different measures were used. Meta-regression analyses were 
carried out to examine whether the severity of depressive or negative symptoms moderated 
the findings. Finally, meta-regression analyses were conducted to assess whether age, gender, 
ethnicity or diagnosis in the sample moderated the findings.  
 For all analyses, heterogeneity statistics (I2 and τ2) are reported to examine the amount 
of variance across studies. The I2 statistic was included as it has greater power to detect true 
heterogeneity when analyses only include a small number of studies. The convention is to 
consider an I2 statistic higher than 25%, 50% or 75% as representing low, moderate or high 
heterogeneity respectively. The τ2 statistic measures the between-study variance in the meta-
analyses and a value >1 is suggestive of very high heterogeneity (Deeks, Altman, & Bradburn, 
2008). Rather than the 95% confidence interval, the more rigorous 95% prediction interval,  






effect sizes in future studies can be expected to fall, is reported for the main effect (Borenstein 
et al., 2009).  
 Publication and other biases can be introduced through the systematic review process 
and this can influence the findings when conducting a meta-analysis. Publication bias was 
assessed with a visual inspection of the funnel plots and using Egger’s test for asymmetry 
(Egger, Smith, Schneider, & Minder, 1997). Begg’s test was also conducted which makes fewer 
assumptions than Egger’s test and has sufficient power to detect bias in a meta-analysis of this 
size (Begg & Mazumdar, 1994). All publication bias analyses were conducted using the 














































Literature search  
Databases: Embase, PsycInfo, Medline 




























Records after duplicates removed 
(k = 3232) 
Records screened 
(n = 2020) 
Records excluded 
(k = 1175) 
Full-text articles assessed 
for eligibility 
(n =845) 
Full-text articles excluded, with 
reasons: (k = 787) 
 
Direct relationship between depression 
and negative symptoms was not 
analysed (k = 335) 
 
No validated measure of depression in 
psychosis (k = 355) 
 
Participants with depression excluded 
from sample (k = 2) 
 
No validated measure of negative 
symptoms in psychosis (k = 4) 
 
Sample did not have a diagnosis of non-
affective psychosis (k = 63) 
 
Not an experimental article (k = 26) 
 




Studies included in 
quantitative synthesis 
(k = 56) 
Authors did not respond to request for 
additional data 






Characteristics of studies  
Fifty-six papers were included in the analyses, see PRISMA flow diagram in Figure 1. The 
included studies are summarised in Table 1 below. Based on the data available, there were 
8,177 unique participants in these studies and 66.79% were male. The mean age reported for 
the samples ranged from 22.3 – 59.35 with a composite mean age of 37.16 (SD = 9.58). Two 
studies selected people aged over 40 years old for inclusion in their sample (Mausbach, 
Cardenas, Goldman, & Patterson, 2007; Zisook et al., 1999). However, two studies did not 
report mean age or gender for their samples (Addington, Addington, & Maticka-Tyndale, 1994; 
Chemerinski, Bowie, Anderson, & Harvey, 2008) and one further study did not report mean age 
(Norman, Manchanda, Harricharan, & Northcott, 2015). Only ten studies reported the ethnicity 
of the sample, with an average of 49.25% of participants in a BME category.  This composite 
categorisation was compared to a composite category of “White” for the purposes of the 
meta-analysis to maximise power. Thirty-four of the studies included in the analyses only 
included people with a diagnosis of schizophrenia. Of the 23 studies that did include people 
with schizoaffective disorder, only 10 reported the percentage of their sample that had this 
diagnosis, with a mean of 16.12%. The majority of studies (k = 48) reported findings from 
community samples, two studies included mixed inpatient and outpatient participants and 
three studies included people solely from an inpatient setting. Three studies reported findings 
from participants experiencing their first or second episode of psychosis. It is relevant to note 
that 9 of the included studies were focused on the validation of a measure of negative 
symptoms, sometimes in translated form. The other 47 studies report on a variety of 
experimental and cross-sectional investigations. 
 






Study Authors & 
Publication 
Year 



























1 Couture et 
al, 2011 
 
62 62.9 46.7 
(8.4) 




Expr= -0.08  




2 Grant et al, 
2009 
55 65 36.9 
(9.9) 
Y (9) BDI 13 (11.5) SANS 23.7 (12.1) .20  >.05 10  
3 Uzenoff et 
al, 2010 
41  58.5 22.3 
(3.5) 




0.07 >.05 10  
4 Grant et al, 
2010 
123 65.8 38.6 
(12.1) 
Y (17.9) BDI 17.1 (12.5) SANS 27.2 (11.9) 0.18  <.05 10  
5 Roseman et 
al, 2008 




CDSS  NR PANSS 
Neg 
NR 0.11  >.05 10  
6 Mausbach 
et al, 2007 
210  23 51.30 
(7.54) 






0.34 <.05 9  
7 Freeman et 
al, 2006 
187 72 37.5 
(10.9) 
Y (11) BDI  21.6 (13.0) PANSS 
Neg 
21.0 (6.2) .28 <.001 11  
8 Todarello et 
al, 2005 
29 75.9 39.1 
(10.9) 
Y  MADRS 21.9 (8.3) PANSS 
Neg 
28.4 (10.5) 0.25 >.05 10  
9 Fitzgerald et 
al, 2002 
309 64.1 34.05 
(10.6) 
Y MADRS 14.6 (9.07) PANSS 
Neg 
19.55 .40 =.000 12  
10 Muller et al, 
2002 
57 63 42.9 
(11.8) 
Y (7) CDSS 9 (6.3) PANSS 
Neg 
18.4 (7.4) .54  <.001 8  
11 Malla et al, 
2002 
110  72 24.9 
(7.8) 
Y (7.3) CDSS 3.3 (3.7) SANS 10.2 (2.5) Expr = 0.20 




12 Brebion et 
al, 2001 
40 70 34.1 
(11.1) 
Y  HAM-D 8 (5.2) SANS 8.4 (4.3) 0.34 <.05 10  
13 Peralta et 
al, 2000 
47 70 26.9 
(9.1) 






14 Wolthaus et 
al, 2000 
138 76.8 23.2 
(5.26) 
Y (10.1) MADRS NR PANSS 
Neg  
NR 0.51 <.001 12  
15 Zisook et al, 
1999 
60 50 59.35 
(10) 











16 Peralta et 
al, 1999 
45 63.6 31.6 
(12.8) 
N CDSS 3.6 (4.8) PANSS- 
Neg 
12.5 (5.8) 0.21 >.05 9  
17 Lancon et 
al, 2000 

















18 Brebion et 
al, 2000 
40 70 34.1 
(11.1) 










et al, 2000 














20 Baynes et 
al, 2000 













21 Kilzeih et al, 
2003 
43 97.7 43.05 
(7.05) 
N HDRS 6.84 (4.25) SANS 62.23 
(17.41) 
.19 >.05 10  
22 Bottlender 
et al, 2003 
33 66.67 32.15 
(9.12) 
N MADRS 18.3 (8.8) SANS 55.5 (24.4) 0.15 .41 10  
23 Rocca et al, 
2005 
78 59 36.13 
(8.93) 
N CDSS 3.77(3.0) PANSS - 
NEG 
17.1 (9.52) 0.42 <.001 10  
24 Chemerinski 
et al, 2008 
230 NR NR  N BDI 11.5 (9.6) PANSS-
NEG 
NR 0.14  .03 9  
25 Schennach-
Wolff et al, 
2011 
249  61 34.1 
(11.09) 








NR 9  
26 Rabany et 
al, 2011 
240 73.3 36.99 
(12.21) 




- .184 .012 11  
27 Addington 
et al, 1994 
150  NR NR N CDSS  4.1(4.28) PANSS-
NEG 
20.15(4.84) 0.27  <.01 10  
28 McAdams 
et al, 1996 
101 77 58.5 
(9.7) 







et al, 1996 
89 60 35.3 
(10.3) 











30 Collins et al, 
1996 











31 Nakaya et 
al, 1997 
89 45 31.19 
(9.6) 
N HDRS 16.5 (7.3) PANSS  23.9 (4.7) 0.20  >.05 13  
32 Collins et al, 
1997 
58 77.6 34.10 
(8.01) 




0.178 >.05 8  
33 Norman et 
al, 1998 









34 Haug et al, 
2016 
55 51 25.2 
(7.3) 
Y CDSS 9.1 (6.0) PANSS 
Neg 
14.1 (6.7) -0.289  0.032 10  
35 Norman et 
al, 2015 





36 Fervaha et 
al, 2015 
62 67.7 26.3 
(3.9) 
N CDSS 1.8 (2.7) SANS 11.5 (6.7) 0.21 >.05 10  
37 Bozikas et 
al, 2016 
48 62.5 32.81 
(7.74) 




0.404 <.01 12  
38 Kjelby et al, 
2015 
124 68.5 37.2 
(13.1) 
Y CDSS 5.44 (4.8) PANSS 
Neg 
20.6 (7.95) 0.15 <.05 10  
39 Alessandrini 
et al, 2016 
271 70.8 36.1 
(11.9) 
N CDSS 4.2 (4.4) PANSS 
Neg 
20 (8.0) 0.17  >.05 11  
40 Best et al, 
2014 
136 73.5 56.08 
(9.23) 
Y BDI NR PANSS 
Neg 
NR .21 .019 10  
41 DeRosse et 
al, 2014 
184 69.02 40.98 
(11.07) 




0.32  <.001 8  
42 Fervaha et 
al, 2014 
1427 74.2 40.6 
(11.1) 
N CDSS 4.6 (4.4) PANSS 
Neg 
19.3 (6.7) 0.18 <.001 11  
43 Ricarte et 
al, 2014 
31 80.6 38.5 
(10.6) 






.15  >.05 9  
44 Rabany et 
al, 2013 
184 74.5 36.37 
(12.58) 










45 Lin et al, 
2013 
302 61.3 38.17 
(9.48) 
N HDRS 5.89 (4.20) SANS 50.42 
(15.97) 
.265  <.001 11  
46 Tapp et al, 
2001 
104 65 30 (9) N HDRS 13.5 (4.14) SANS NR .47 <.0001 10  
47 Roche et al, 
2010 
67 70.1 25 
(9.78) 
N CDSS 2.16 (3.07) PANSS 
Neg 
NR  .005 >.05 9  
48 Kring et al, 
2013 
162 57 46.8 
(9.5) 













49 Llerena et 
al, 2013 
37 64.9 50.16 
(5.12) 
Y CDSS 1.11 (1.88) MAP-SR NR .13 >.05 10  
50 Kontaxakis 
et al, 2000b 
64 61 30.3 
(8.9) 




0.123 >.05 10  
51 Sarro et al, 
2004 
93 60.2 37.2 
(10.4) 
N CDSS 4.1 (4.4) PANSS 
Neg 
19.8 (8.9)  0.239 <.01 10  
52 Polat Nazli 
et al, 2016 
65 76 34.6 
(8.3) 
N CDSS 2.5 (3.8) BNSS 29.4 (17.6) -.013 .91 11  
53 Engel et al, 
2016 
50 56 35.7 
(10.36) 








100 74 40.98 
(12.5) 


















55 Mucci et al, 
2015 
912 69.8 40.1 
(10.7) 
N CDSS 4.0 (4.0) BNSS  NR 0.28 <.00001 11  
56 Kim et al, 
2016 
139 54.7 38.9 
(11.1) 








Quality Ratings of Studies  
 
The quality ratings in each area are summarised for the studies in Table 2 below. Studies 
generally scored moderate – high in the selection bias section with the majority recruiting from 
a wide pool of participants. Studies scored lower in this area when they sampled from clinic, 
service or ward only or their recruitment procedure was not described clearly. The majority of 
studies stated hypotheses regarding the relationship between depression and negative 
symptoms and tested this appropriately – scoring the single mark available for this section. The 
use of valid and reliable measures was an inclusion criterion for the review and therefore all 
studies scored at least 2 in this scale. Studies did not consistently report subscales for the 
negative symptom measures used and this prevented them from achieving the full score in this 
section. The studies included in this meta-analysis were thorough in reporting missing data and 
accounting for this in analyses where appropriate, scores were therefore high in this section 
unless the study did not account for this. The studies included all conducted appropriate 
correlational analyses as this was a criterion for inclusion in the meta-analysis. The lower 
scores in this section are given to studies which do not account for multiple correlational 



























1 2 1 3 3 2 11 
2 2 1 2 3 2 10 
3 2 1 2 3 2 10 
4 2 1 2 3 2 10 
5 2 1 2 3 2 10 
6 2 1 2 3 1 9 
7 3 1 2 3 2 11 
8 3 1 2 3 1 10 
9 2 1 3 3 3 12 
10 1 0 2 3 2 8 
11 3 1 3 3 3 13 
12 2 1 3 2 2 10 
13 1 1 2 3 2 9 
14 2 1 3 3 3 12 
15 2 1 2 2 3 10 
16 1 1 2 3 2 9 






18 2 1 3 2 2 10 
19 1 1 2 3 2 9 
20 3 1 3 3 3 13 
21 1 1 2 3 3 10 
22 1 1 2 3 3 10 
23 1 1 2 3 3 10 
24 1 1 2 3 2 9 
25 3 1 2 1 2 9 
26 2 1 3 3 2 11 
27 2 1 2 3 2 10 
28 2 1 2 3 2 10 
29 1 1 2 2 2 8 
30 1 1 2 3 2 9 
31 4 1 2 3 3 13 
32 1 0 2 3 2 8 
33 2 1 2 3 2 10 
34 2 1 2 3 2 10 
35 1 1 3 3 2 10 
36 1 1 3 3 2 10 
37 4 1 2 3 2 12 
38 2 1 2 3 2 10 
39 2 1 2 3 3 11 






41 1 0 2 3 2 8 
42 3 1 2 3 2 11 
43 1 1 2 3 2 9 
44 2 1 2 2 2 9 
45 2 1 2 3 3 11 
46 1 1 2 3 3 10 
47 3 1 2 1 2 9 
48 2 1 3 3 2 11 
49 1 1 3 3 2 10 
50 1 1 2 3 3 10 
51 1 1 2 3 3 10 
52 2 1 3 3 2 11 
53 2 1 2 3 3 11 
54 2 1 3 3 2 11 
55 2 1 2 3 3 11 









Measures of negative symptoms  
Four measures of negative symptoms were used in the studies included in the analysis; 
these are detailed in Table 1. The most commonly used assessment was the negative 
symptom subscale of the Positive and Negative Syndrome Scale (PANSS) (Kay, Fiszbein, & 
Opler, 1987) with 34 studies using this measure. The second most common was also an 
older measure of negative symptoms – the Scale for the Assessment of Negative Symptoms 
(SANS) (Andreasen, 1989) with 17 studies using this measure. These measures are the most 
widely used which reflect the historical conceptualisation of primary and secondary 
negative symptoms. The newer measures – the Clinical Assessment Interview for Negative 
Symptoms (CAINS) (Forbes et al., 2010)(k = 5) and the Brief Negative Symptom Scale (BNSS) 
(Kirkpatrick et al., 2011)(k=2) were used far less often in these studies. All these measures 
take the form of a semi-structured interview conducted by the researcher who then assigns 
scores for the different items on the scale using behavioural anchor points provided. On all 
of these assessments a higher score reflects more severe symptoms. The most important 
differences in the newer measures is that they draw a distinction between expressive and 
experiential symptoms.  The CAINS also has a self-report scale developed from its 
experiential subscale – the Motivation and Pleasure Scale – Self Report which is used in 3 
studies. The SANS is a detailed measure with 5 subscales that have been retrospectively 
divided into expressive and experiential symptoms, but this was not specified in its 
development and validation. The PANSS and Brief Psychiatric Rating Scale (BPRS) (k =2) 
(Overall & Gorham, 1962) do not consider expressive and experiential symptoms 
separately. Where these data were reported, expressive and experiential subscales from 
the CAINS, BNSS and SANS were analysed separately in the sub-group meta-analyses. Three 
is the minimum number of studies needed to conduct a robust sub-group analysis and 







Measures of depression  
Four measures of depression were used in the sample of studies included in the analyses; 
these are also detailed in Table 1. The most commonly used measure was the Calgary 
Depression Scale for Schizophrenia (CDSS, k = 34) (Addington, Addington, & Schissel, 1990). 
This measure was developed specifically for use in this population and the scale was 
developed not to include items which overlap with negative symptoms. The CDSS is a semi-
structured interview with only 9 items and a recent review (Lako et al., 2012) concluded 
that this measure most reliably distinguishes depressive from negative symptoms in people 
with schizophrenia. The second most common measure was the Hamilton Depression 
Rating Scale (HDRS, k = 16) (Hamilton, 1960) which is a more general measure used in many 
different populations and includes many of the physical symptoms of depression. It is a 
clinician-rated measure and the 17-item version was commonly used in these studies. The 
other two measures used, the Beck Depression Inventory (BDI, k = 9) (Beck, Steer, & Carbin, 
1988) and the Montgomery-Asberg Depression Rating Scale (MADRS, k = 5) (Williams & 
Kobak, 2008), were developed initially for the assessment of people with mood disorders 
and include the full range of depressive symptoms, including cognitive features such as 
hopelessness and low self-esteem. The BDI can be used as a self-report measure but the 
MADRS is a clinician-rated interview.  
Meta-Analysis Findings  
1. Is there a relationship between negative symptoms and depression in 
people with psychosis? 
The meta-analysis testing the relationship between negative symptoms and 
depression showed a small but significant association between increased levels of 






affective psychosis (k = 56, pooled effect size (ES) = 0.194, 95% confidence interval 
(CI)=0.141, 0.247, z = 7.20, p<.001) (See Figure 2).  
2. Does this relationship vary according to depression or negative symptom 
measures or subscales used?  
The relationship was consistently present across the sub-group analyses looking at 
each depression and negative symptoms measure. When the most common 
combination– PANSS Neg and CDSS- was examined the effect size was also small 
but significant (k = 23, pooled ES=0.135, 95% CI= 0.055, 0.216, z = 3.29, p=.001). 
The expressive (k =6, pooled ES= 0.189, 95% CI=0.090, 0.288, z= 3.75, p<.001) and 
experiential (k=12, pooled ES=0.263, 95% CI= 0.185, 0.341, z=6.58, p<.001) 
subscales also had small but significant relationships with measures of depression 
which was numerically larger for experiential subscales. However, a significantly 
higher relationship cannot be concluded definitively as the CIs for the pooled ESs 
slightly overlap. 
Heterogeneity analyses  
The full sample included in the main effect analyses showed high levels of 
heterogeneity (p<.001, I2=79.5%, τ2=0.0283) as expected given the wide range of 
different measures used. The 95% prediction interval (-0.15, .54) is displayed 
around the main effect size in the Forest Plot (See Figure 2). 
In line with this the heterogeneity was lower in the sub-groups analyses (See 
Appendix for full results) and for expressive (p=.216, I2=29.3%, τ2=0.0308) and 
experiential (p=.263, I2=25.3%, τ2=0.007) subscales the heterogeneity was even 






Publication bias  
Visual inspection of the funnel plots showed publication bias to be unlikely. This 
was confirmed by the Egger’s and Begg’s tests conducted which found no evidence 
of publication bias in the main effect analyses (Egger’s p=0.962, Begg’s p=0.772). 
This was consistent across the negative symptom (Egger’s p=0.138-0.932, Begg’s 
p=0.621-1.0) and depression measures used (Egger’s p=0.224-0.687, Begg’s 
p=0.419-0.917).  
3. Is this relationship moderated by depressive or negative symptom 
severity? 
Meta-regression analyses using the subset of the full sample that reported severity 
scores showed that the severity of depressive symptoms positively predicted a 
relationship with negative symptoms (k=51, t=2.08, p=.044). Negative symptom 
severity also predicted the association with depressive symptoms but in the 
opposite direction (k=43, t= -2.45, p=0.019). As these analyses included the whole 
sample the heterogeneity was high (I2res = 78.13%, 73.84%, τ2=.02579, .02569) and 
thus the results should be considered in this context.  
4. Is this relationship moderated by the diagnosis of the sample, quality of 
the study or demographic factors? 
To investigate whether variables which differ between sample populations account 
for heterogeneity in findings meta-regression analyses were conducted for 
demographic data and study characteristics including those studies which reported 
this data (see Table 1). No significant results were found for age, gender or 
ethnicity (ts=0.10-0.85, ps=0.418-0.924). The proportion of the sample with 






p=0.829). The quality ratings for each study were also examined to assess whether 
this moderates the presence of an association between the measures, this analysis 


































Figure 2: Forest Plot of Relationship between Negative and Depressive Symptoms.   
 
Main effect (95% CIs). Red line around main effect represents 95% prediction interval (-0.15 – 0.54) based on 







The findings confirm that there is a relationship between negative symptoms and 
depressive symptoms in people with non-affective psychosis. In the first large meta-
analysis to examine this, with data from 56 studies and over 8,000 unique participants, and 
across a range of measures, a clear pattern emerges showing that higher ratings of 
negative symptoms are associated with higher levels of depressive symptoms, with a small 
effect. The relationship was consistent across measures, so it does not appear to be the 
result of measurement artefacts. The effect size did vary with the measure used, but not 
greatly. There were no significant moderating effects of demographic or study quality 
variables suggesting it is robust and generalisable. A non-reciprocal relationship was 
highlighted in the findings – higher depression severity was linked to higher negative 
symptom severity but there was an inverse relationship in the other direction whereby 
higher negative symptom severity was linked to lower depression severity. All these 
findings support the hypothesis that this relationship represents occurrence in the 
individuals’ experiences as well as phenomenological overlap in these concepts.  
 
These findings support the model proposed in the recent review by Krynicki et al. (2018) 
which suggests that a dimensional approach to these symptom clusters may best represent 
this relationship. This approach allows some co-occurrence of these symptoms which the 
evidence suggests is present. Depression may act as a driver of negative symptoms as 
proposed in cognitive models of psychosis which highlight the role of emotion in the 
development of other symptoms e.g. (Garety et al., 2001). Depressive symptoms may also 
be present because of the impact of negative symptoms on the individual’s functioning 







The other factor which may contribute to this relationship is phenomenological overlap in 
the concepts of negative and depressive symptoms. The expressive and experiential 
symptoms within the negative symptom cluster are important to consider separately in 
their relationship with depression. These sub-group analyses suggested that, as expected, 
the experiential negative symptoms have a stronger relationship with depression than the 
expressive symptoms. These symptoms of low motivation, apathy and anhedonia are 
present in the majority of both the negative and depressive symptom measures used in the 
studies in this meta-analysis. Measures such as the CDSS have attempted to reduce 
phenomenological overlap by excluding these symptoms in their assessment of depression 
but whether this is a valid approach to measuring depressive symptoms is yet to be 
addressed. This meta-analysis found a small effect suggesting there are areas where the 
two symptom dimensions are phenomenologically distinct using current measures. It 
seems from recent reviews of the area that suicidal ideation, pessimism and guilt are more 
commonly present due to depressive symptoms. Expressive symptoms, with poorer verbal 
and emotional expression, are more uniquely found in people experiencing negative 
symptoms. Clinicians supporting individuals with low motivation and functioning should 
perhaps assess additionally those areas uniquely associated with the depressive or negative 
symptom dimensions. Low motivation and functioning can then be considered in this wider 
context to better identify the contributions of negative and depressive symptoms to the 
individual’s difficulties. Newer measures of negative symptoms and specific cognitive 
measures in depression e.g. Beck Hopelessness Scale (Beck, Weissman, Lester, & Trexler, 
1974) should be considered in this approach.  
 
Importantly, these findings were not moderated by demographic variables such as age, 
gender and ethnicity suggesting this relationship is present across the course of the illness 






did not moderate the findings, although there was a limited range of scores as a result of 
the measure used and inclusion criteria applied to the studies. A lot of the studies included 
people with a diagnosis of schizoaffective disorder in their sample and this did not 
moderate the findings. This is perhaps surprising as people with schizoaffective disorder 
might be expected to report more symptoms related to mood. It suggests, although 
tentatively, that the overlap between depressive and negative symptoms is part of the 
psychosis spectrum of symptoms. This fits with cognitive models of psychosis which 
propose a central role of emotion across the psychosis spectrum e.g. (Freeman & Garety, 
2003; Garety et al., 2001).   
 
The findings of the meta-regressions showed a non-reciprocal relationship between 
negative and depressive symptoms. The higher the depressive symptoms reported the 
more likely they are to demonstrate a positive association with negative symptoms. 
However, if a person reports higher negative symptoms the less likely they are to be 
related to depressive symptoms. This is a cross-sectional finding and hypotheses regarding 
a directional relationship are therefore speculative at this stage. As negative symptom 
severity increases the person is more likely to experience expressive deficits and greater 
apathy, or numbing of emotion. This may either limit their ability to report depressive 
symptoms or be protective against them. It is important to consider that depressive 
symptoms are more often self-reported whereas negative symptoms are always 
interviewer-rated. This may explain this non-reciprocal relationship in terms of how 
symptoms are expressed in an interview – which may be more challenging for someone 
with high negative symptoms. Negative symptoms may also be a less potent bridge to co-
occurring depressive symptoms.  The role of depressive symptoms in driving psychosis has 
been discussed previously and it may be that this is a more potent route to co-occuring 







Limitations of the Review  
The main analysis and some of the sub-group analyses had high heterogeneity in the 
studies include which is a limitation of including different measures in the analysis, 
although this did increase power. Only two studies were excluded due to missing data, 
however many studies did not report the demographics of the sample who completed the 
measures included in this meta-analysis. This limits the conclusions that can be drawn 
regarding the impact of these variables, particularly ethnicity which was only reported in 10 
studies. Meta-analyses that consider symptoms are only as good as the measures of those 
symptoms that were used. Several studies did not report the total scores for the measures 
they used and so they could not be included in the meta-regressions conducted, which 
limits these findings. This review reports interesting findings regarding the negative and 
depressive symptom measures and it is important to note that they do not represent a 
homogenous measurement process. More robust conclusions would have been possible 
with a greater number of studies in the sub-group analyses considering separately 
expressive and experiential symptoms. Further hypotheses regarding the relationship 
identified are limited by the lack of depression sub-scales reported in these studies e.g. 
somatic, cognitive, behavioural. The narrow range of quality ratings provided by the scale 
used highlights the limitations in applying quality assessment scales to studies included in a 
rigorous meta-analysis with methodological inclusion and exclusion criteria. This may have 
limited the power of the moderation analysis of the quality of the studies on the findings.  
 
Clinical Implications  
The most important clinical implication of these findings is that depressive and negative 
symptoms can both be present in people with non-affective psychosis. This means both 






follows that treatment for both sets of symptoms might be indicated, although further 
research is required to explore whether this requires targeting the same or different causal 
mechanisms. These findings also suggest that to capture fully the range of both groups of 
symptoms, care should be taken in the selection of measures. For depression, measures 
such as the BDI and CDSS should be used – as they are comprehensive assessments of the 
symptoms which seem to be more relevant to the depressive dimension i.e. pessimism, 
suicidal ideation and somatic symptoms.  For negative symptoms, clinicians should also 
prioritise using newer measures which assess anticipatory and consummatory pleasure 
separately as well as reporting separate subscales for expressive and experiential 
symptoms which have been shown to be robust. By using this combination of measures the 
assessment will provide a full picture of the difficulties the individual is currently 
experiencing and will also suggest the specific contributing areas of negative and 
depressive symptomatology.  
 
The findings of this meta-analysis highlight the importance of mood across the psychosis 
spectrum as proposed in several cognitive models of psychosis e.g. (Birchwood, 2003; 
Chadwick, Birchwood, & Trower, 1996; Freeman, Garety, Kuipers, Fowler, & Bebbington, 
2002; Garety et al., 2001). A dimensional approach to considering these symptoms across 
the traditional depression/negative symptoms divide may have the highest clinical utility 
(van Os & Reininghaus, 2016). Indeed, depressive symptoms have also been shown to be 
associated with other dimensions within psychosis, including positive symptoms (Hartley, 
Barrowclough, & Haddock, 2013). To this end, targeting specific constructs when 
intervening e.g. low motivation or hopelessness may be a useful approach going forwards 
in both clinical work and research. Clinicians working in this area may consider using 
approaches targeting these symptoms from other fields such as depression or motivational 






clear intervention to provide; several different approaches – family therapy, social skills 
training and Cognitive Remediation Therapy (CRT) have been shown to have an impact on 
negative symptoms (Cella, Preti, Edwards, Dow, & Wykes, 2017; Elis, Caponigro, & Kring, 
2013; Lutgens, Gariepy, & Malla, 2017) but this is often as a secondary outcome and not a 
primary target. There is one trial of long-term CBT targeting negative symptoms which 
found a significant improvement in apathy (Grant, Huh, Perivoliotis, Stolar, & Beck, 2012). 
CBTp trials often report improvement in depressive symptoms (Peters et al., 2015; Wykes, 
Steel, Everitt, & Tarrier, 2008) but the benefit for negative symptoms is less clear (Velthorst 
et al., 2015). However, a recent large-scale study (Super-EDEN) in the UK has shown that 
levels of depressive symptoms at baseline can worsen the trajectory of negative symptoms 
suggesting that early intervention in both these dimensions is important (Gee et al., 2016). 
It may be that therapy needs to be further adapted to target negative symptoms and the 
findings of this meta-analysis suggest approaches that have been successful in depression 
could also be effective in alleviating negative symptoms, especially in the milder range.  
 
Future Research  
The large majority of studies included in this meta-analysis used older measures of negative 
symptoms and did not report experiential and expressive subscales. This limits our 
understanding of how to best assess and understand the relationship with depression. 
Future research studies should use newer measures of negative symptoms i.e. CAINS or 
BNSS and should always report the expressive and experiential subscales. Similarly, it is 
positive that so many studies measure depressive symptomatology using validated scales. 
However, subscales are not reported and given the wide range of depressive 
symptomatology this means our understanding of how people with non-affective psychosis 
experience of depression is very limited. Studies should report separately somatic and 






symptoms. The high levels of heterogeneity in this analysis reflect the wide range of 
measures used and thus to improve the robustness of future meta-analyses consistent 
approaches to the measurement of depression and negative symptoms should be adopted. 
Focusing on newer measures of negative symptoms and validated depression measures will 
ensure this.  
 
Trials of new, targeted psychological interventions for negative and depressive symptoms 
in non-affective psychosis should be a priority. Theoretical understanding of their causes 
and maintenance factors, to identify optimal treatment targets is similarly important. The 
impact of these symptoms is at least as, if not more significant than any other group of 
symptoms and they are a priority for service users (Rose, 2014). The findings of this meta-
analysis show that there is a relationship between these two symptom dimensions and 
considering negative symptoms and depression as separate diagnostic categories is no 
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Sub-Group Effect Analyses  
The negative symptom measures all demonstrated a small but significant relationship with 
depressive symptoms (all measures included) in the sub-group analyses; the CAINS (k=5, 
pooled ES=0.188, 95% CI=0.046-0.330, z=2.59, p=0.01), SANS (k=18, pooled ES=0.281, 95% 
CI=0.219-0.343, z=8.87, p<.001) and PANSS-Neg (k=34, pooled ES=0.162, 95% CI=0.089-
0.234, z=24.35, p<.001). The SANS showed the strongest relationship with depressive 
symptoms and the PANSS-Neg had the smallest effect size – this may reflect the larger 
number of items and therefore wider range of symptoms assessed by the SANS.  
 
The depression measures also demonstrated a consistent small but significant relationship 
with negative symptoms (all measures included). The MADRS (k=5, pooled ES=0.334, 95% 
CI=0.162-0.506, z=3.81, p<.001), the BDI (k=9, pooled ES=0.198, 95% CI=0.135-0.261, 
z=26.14, p<.001), the HDRS (k=16, pooled ES=0.284, 95% CI=0.212-0.357, z=7.68, p<.001) 
and the CDSS (k=35, pooled ES=0.156, 95% CI=0.095-0.217, z=5.01, p<.001). the MADRS 
showed the strongest association with negative symptoms although the number of studies 
is small. The CDSS had the smallest effect size and this supports the conclusion of the Lako 
et al, 2012 review that this measure of depression most reliably distinguishes from negative 
symptoms in psychosis.  
 
Heterogeneity in Sub-Group Analyses  
 
The negative symptom measures vary in the heterogeneity in the studies included, perhaps 






shows low heterogeneity (p=.080, I2=34.5%, τ2=0.0055) and the CAINS is moderate (p=.046, 
I2=58.6%, τ2=0.0149). The PANSS-Neg, which is most commonly used has high 
heterogeneity at a similar level to the main effect analysis (p<.000, I2=81.6%, τ2=0.0308).  
The depression measures showed moderate heterogeneity (ps<.05, I2=48.3-75.4%, 
τ2=0.0097-0.0242) with the exception of the BDI which showed very low heterogeneity 
amongst the 9 studies included in the analysis (p=.701, I2=0.0%, τ2=0.0000). These statistics 

























Quality Assessment Tool for Quantitative Studies- Adapted Version  
 
COMPONENT SCORES  
A) SELECTION BIAS  
(Q1) Are the individuals selected to participate in the study likely to be representative of 
the target population?  
4  Very likely  
3  Somewhat likely  
2  Not likely  
1  Can’t Tell  
 
(Q2) What percentage of selected individuals agreed to participate? 
4  80-100% agreement    
3  60-79% agreement  
2  <60% agreement  
1 Can’t Tell  
Score this 
section 
Very Strong  Strong Moderate Weak 
 4 3 2 1 
 
B) STUDY DESIGN  
(Q3) Was there a clear hypothesis stated and matching design for the study?  
0  No 








C) DATA COLLECTION METHODS  
(Q4) Were data collection tools shown to be valid? 
 3  Yes  
2  No  
1  Can’t tell  
 
(Q5) Were data collection tools shown to be reliable?  
3  Yes  
2  No  
1 Can’t tell 
 
(Q6) Are dimensional scales reported for negative symptoms?  
0 No  
1 Yes 
Score this section Strong Moderate Weak 
 3 2 1 
 
D) MISSING DATA  
(Q7) Were missing data reported in terms of numbers and/or reasons?  
3  Yes  
2  No  
1  Can’t tell 
 
(Q8) Indicate the percentage of participants completing the study.  






3  60 - 79%  
2  less than 60%  
1  Can’t tell  
 
Score this section Strong Moderate Weak 
 3 2 1 
 
E) ANALYSES  
(Q9) Are the statistical methods appropriate for the study design?  
3  Yes  
2 No  
1 Can’t tell 




1 Can’t Tell  
Score this section Strong Moderate Weak 












Quality Assessment Tool for Quantitative Studies: Guidance for Scoring 
  
A) SELECTION BIAS 
(Q1) Participants are more likely to be representative of the target population if they are 
randomly selected from a comprehensive list of individuals in the target population (score 
very likely).  
They may not be representative if they are referred from a single setting (e.g. outpatient or 
inpatients only) in a systematic manner (score somewhat likely).  
The sample is even less likely to be representative if from a single ward or service or if they 
have self-referred (score not likely).  
(Q2) Refers to the % of subjects in the control and intervention groups that agreed to 
participate in the study before they were assigned to intervention or control groups. If this 
is not reported then score this as “can’t tell”.  
A Overall Score(1-3) 
Very Strong: The selected individuals are very likely to be representative of the target 
population (Q1 is 4) and there is greater than 80% participation (Q2 is 4). 
Strong: The selected individuals are at least somewhat likely to be representative of the 
target population (Q1 is 4 or 3); and there is 60 - 79% participation (Q2 is 3). 
 Moderate: The selected individuals are at least somewhat likely to be representative of the 
target population (Q1 is 4 or 3); and participation is not described (Q2 is 1) or below <60% 
(Q2 is 2).   
Weak: The selected individuals are not likely to be representative of the target population 
(Q1 is 2); or there is less than 60% participation (Q2 is 2) or selection is not described (Q1 is 








B) STUDY DESIGN 
Q3) Important to consider whether a clear hypothesis was stated and the design of the 
study was appropriate to address this (Yes/No).  
 
C) DATA COLLECTION METHODS  
Q4,5) Tools for primary outcome measures must be described as reliable and valid. If ‘face’ 
validity or ‘content’ validity has been demonstrated, this is acceptable.  
Reliability and validity can be reported in the study or in a separate study. For example, 
some standard assessment tools have known reliability and validity. 
Additional question inserted regarding the method of reporting the subscales as 
dimensional scales considered to be of a higher standard particularly in the field of negative 
symptoms.  
C Overall Score (1-3)  
Strong: The data collection tools have been shown to be valid (Q4 is 3); and the data 
collection tools have been shown to be reliable (Q5 is 3). Dimensions are reported rather 
than only total scale scores.  
Moderate: The data collection tools have been shown to be valid (Q4 is 3); and the data 
collection tools have not been shown to be reliable (Q5 is 2) or reliability is not described 
(Q5 is 1). Dimensions are either reported or omitted (1 or 0). 
Weak: The data collection tools have not been shown to be valid (Q4 is 2) or both reliability 
and validity are not described (Q4 is 1 and Q5 is 1).  
 
D) WITHDRAWALS AND DROP-OUTS  
Q 7,8) Score YES if the authors describe BOTH the numbers and reasons for withdrawals 
and drop-outs. Score NO if either the numbers or reasons for withdrawals and drop-outs 






The percentage of participants completing the study refers to the % of subjects remaining 
in the study at the final data collection period in all groups (i.e. control and intervention 
groups). 
D Overall Score (1-3)  
Strong: will be assigned when the completion rate is 80% or greater (Q7 is 4).  
Moderate: will be assigned when the completion rate is 60 – 79% (Q8 is 3). 
Weak: will be assigned when a completion rate is less than 60% (Q8 is 2) or any missing 
data were not described (Q8 is 1). 
 
E) ANALYSIS APPROPRIATE TO QUESTION  
E Overall Score (1-3)  
Strong: will be assigned when the analysis is appropriate and the significance level accounts 
for the number of comparisons conducted (Q9 and 10 are both 3) 
Moderate: will be assigned when the analysis is appropriate but the significance level has 
not been adapted. (Q9 is 3 and Q10 is 2) 
Weak: will be assigned the suitability of the analyses and the adjustment of the significance 
level is not clear (Q9 and 10 are 1).  
Maximum Possible Score: 14 
 
Original sections: C,D and G have been omitted as the only apply to studies which consider 
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People with a diagnosis of psychosis often experience low motivation and reduced activity 
levels. Autobiographical memory retrieval has been shown to be over-general (i.e. lacking 
specific autonoetic details) in people with psychosis and this may limit the ability of 
memories to support motivation. Study 1 aimed to investigate this relationship by 
conducting assessments of autobiographical memory alongside symptom measures. Study 
2 used an up-to-date protocol from the depression field to develop a protocol for targeting 
experiential negative symptoms, such as low motivation, using supported autobiographical 
memory retrieval. This pilot study assessed feasibility and acceptability and preliminary 
effect sizes. The results of Study 1 showed that autobiographical memory deficits are linked 
to self-defeatist beliefs, working memory and functioning but not directly to negative or 
depressive symptoms. Study 2 found that the protocol developed was acceptable and 
feasible to those who took part. Participants were able to generate positive 
autobiographical memories linked to their goals and experience appropriate emotions 
linked to these. The preliminary effect sizes showed encouraging signals for self-efficacy, 
motivation and a reduction in negative mood. These findings suggest that autobiographical 
memory may play a role in reducing functioning and self-efficacy beliefs in people with 
psychosis. Positive memories and emotions are an important therapeutic mechanism and 
guided autobiographical memory retrieval may be an effective way tool for targeting this in 










Psychotic disorders have been shown to be among the top ten causes of disability 
worldwide  (The Schizophrenia Comission, 2012). Psychosis can be conceptualised as 
reflecting five main symptom clusters; excited, cognitive, affective, positive and negative 
e.g. (Wallwork, Fortgang, Hashimoto, Weinberger, & Dickinson, 2012). Positive symptoms 
include delusions and hallucinations and negative symptoms have been defined by the 
National Institute of Mental Health (NIMH) Consensus according to the dimensions of 
anhedonia and apathy, avolition and asociality, poverty of speech and blunted affect 
(Kirkpatrick et al., 2006). Negative symptoms appear to play a significant role in outcomes 
for people with psychosis, as they are associated with poorer social functioning, 
work/school functioning and activities of daily living (Marchesi et al., 2015; Menendez-
Miranda et al., 2015; Robertson et al., 2014). Service users have also identified apathy and 
low motivation as a priority for recovery (Sterk, Winter van Rossum, Muis, & de Haan, 
2013). In a qualitative study, mood and happiness were also highlighted as key to the 
process of recovery (Wood, Price, Morrision, & Haddock, 2013). Despite this wealth of 
evidence highlighting the importance of negative symptoms to service users and therefore 
of developing effective interventions to alleviate negative symptoms, the only 
recommended treatment in the NICE (2014) guidelines is arts therapy, for which the 
evidence for effectiveness is limited. A recent meta-analysis confirmed that available 
treatments show modest effectiveness at best, with many having no effect at all (Fusar-Poli 
et al., 2015). 
Many factor analyses conducted show that negative symptoms are best 
characterized in two broad categories; ‘experiential’ negative symptoms such as apathy, 
anhedonia and asociality and ‘expressive’ negative symptoms including poverty of speech 






shown to account for between 7 and 19% of functional outcomes over an 18-month period 
in people with a diagnosis of schizophrenia, far beyond any other symptomatology 
assessed (Fervaha et al., 2014). One cognitive model that has been proposed for 
experiential negative symptoms is the Temporal Experience of Pleasure Model (Kring & 












The Temporal Experience of Pleasure (TEP) model proposes an important role for 
memory in the generation of anticipatory pleasure and subsequent motivation and 
engagement in activity. It argues that episodic memory is involved, which is defined as the 
memory for specific autobiographical events. These memories for past personal 
experiences allow the person to figuratively travel back in time to the event that took place 
at that particular time and place (Tulving, 1972). Episodic memories are part of 
Figure 1: The Temporal Experience of Pleasure model. Triangles represent pleasure-related processes, ovals represent 































autobiographical memory, which also includes semantic knowledge about the world and 
the self (Conway & Pleydell-Pearce, 2000). The TEP model proposes that during an activity 
the pleasure being experienced is held online in working memory whilst it is encoded into 
episodic memory. When the opportunity to repeat this, or a similar activity, is presented 
the individual retrieves relevant episodic memories and holds these representations online 
in the working memory (Kring & Caponigro, 2010). If there is a failure to retrieve the details 
of a memory or the associated emotion, then this may lead to failure to anticipate pleasure 
from and then repeat that activity. A recent meta-analysis highlights the following areas 
where episodic memory retrieval deficits are consistently reported in people with a 
diagnosis of schizophrenia: memory specificity for past events, richness of memory detail, 
and conscious recollection (Berna, Göritz, et al., 2016).However, links between 
symptomatology and these deficits are unclear in the existing literature. For example, there 
are mixed findings regarding whether there is a link between these impairments and 
experiential negative symptoms (Berna, Göritz, et al., 2016; Harrison & Fowler, 2004; 
Ricarte et al., 2014). One reason for this might be methodological. The methodology used 
across studies to assess memory is relatively consistent, with the autobiographical memory 
test (Williams & Broadbent, 1986) utilised in the majority of studies. This task may have 
some limitations due to its reliance on event cue words e.g. “birthday” rather than specific 
prompting of episodic memories of a particular valence, reducing its ecological validity. It 
may be more valid to prompt the recall of autobiographical episodic memories from an 
individual’s life history. A further limitation of this evidence base is that studies have 
employed negative symptom measures such as the Positive and Negative Syndrome Scale 
(Kay et al., 1987) and the Scale for the Assessment of Negative Symptoms (Andreasen, 
1989). These have been criticized for not accurately discriminating between expressive and 
experiential negative symptoms (Edwards et al., 2015a; Messinger et al., 2011). In sum, 






whether impairments in the retrieval of episodic memories may be linked to negative 
symptoms, experiential or expressive, in psychosis. This study will therefore first examine 
the relationships between autobiographical memory and negative symptoms using the 
most valid measures to address this question.  
As noted above, given their role in recovery and service users views, there is a need 
for new interventions for negative symptoms in psychosis. To improve the effectiveness of 
cognitive-behavioural therapies for psychosis, an interventionist-causal method is 
recommended (Freeman, 2011). The premise of this approach is to focus on one putative 
causal mechanism, demonstrate whether it can be altered and then examine the effect on 
the target symptoms. For example, the causal role of worry and reasoning biases in 
paranoia has been demonstrated, and interventions targeting these processes show 
promise (Freeman et al., 2015; Garety et al., 2014). The foregoing literature suggests that 
impairments in episodic memory may play a causal role in negative symptoms.  
This study will therefore employ a causal interventionist approach to investigating 
the potential causal role of autobiographical episodic memory in negative symptoms. The 
current evidence base relevant to episodic memory in people with a diagnosis of psychosis 
includes two intervention studies. The first primarily targeted the specificity of episodic 
memory and hypothesised a subsequent reduction in depressive symptoms in people with 
persistent psychosis. The intervention was conducted in a group format, with an active 
control condition of occupational therapy and social skills sessions. Participants (n = 24), 
who had low levels of psychosis symptoms at baseline, were encouraged to keep diaries 
with specific daily memories and their associated emotions, which was then extended to 
more historical memories from childhood, adolescence and adulthood. The intervention 
improved memory specificity and depression symptoms but there was no subsequent 






intervention and were assessed using older measures which do not comprehensively assess 
experiential negative symptoms (Ricarte, Hernandez-Viadel, Latorre, & Ros, 2012). Another 
study targeted the potential causal link between over-general memory and low 
anticipatory pleasure for future events, one aspect of experiential negative symptoms. The 
study included 32 participants with schizophrenia-spectrum diagnoses. The results showed 
that recalling a memory in response to event-related cues such as “birthday” or 
“argument” before completing a prospective task enhances anticipatory pleasure for the 
future activity (Painter & Kring, 2016). These studies suggest that interventions targeting 
memory in this population can improve aspects of memory and a recent review highlighted 
the potential for utilising these further in this population (Ricarte, Ros, Latorre, & Watkins, 
2017). But the link with negative symptom outcomes remains to be systematically targeted 
and explored.  
Over-general autobiographical memory does however have a well-established role 
in the symptoms of depression and subsequent reduced functioning (Williams et al., 2007). 
There is a growing evidence base for memory specificity training in depression (Dalgleish et 
al., 2014; Köhler et al., 2015; Neshat-Doost et al., 2012) which has been shown to be 
effective in reducing depressive symptoms during acute and remission periods. As 
described in the meta-analysis presented in this thesis there does appear to be a link 
between negative and depressive symptoms in psychosis, but the nature of this 
relationship is unclear. The effectiveness of these interventions in depression and the link 
between these symptoms further supports piloting these interventions in psychosis. 
Memory specificity training in depression is undergoing some refinement as there may be 
difficulties beyond the retrieval specificity of negative memories.  There also appears to be 
impairment in the ability to generalise from positive events to broader themes in people 
with depression. As well as recalling detail in our episodic memories, “zooming in”, it is 






an event memory to develop and maintain a functional conceptualisation of self in 
autobiographic memory. To reflect these up to date developments in the field the 
intervention utilised in this study will incorporate ideas from the MemFlex approach 
(Hitchcock, Werner-Seidler, Blackwell, & Dalgleish, 2017). Memflex has been developed as 
a self-help intervention where individuals are given the rationale for focusing on their 
autobiographical memory and exercises which practice both “zooming in” and “zooming 
out” to improve both specificity of negative memories and generalisability of positive 
memories.  
The evidence reviewed so far suggests that impairments in episodic memory 
retrieval are present in people with a diagnosis of psychosis. There also appears to be a link 
between depressive and negative symptoms. However, findings regarding the links 
between these episodic memory impairments and symptoms are somewhat equivocal, 
which may be attributable to the limitations of negative symptoms and episodic memory 
measures, and small sample sizes. Robust investigation of the potential causal mechanism 
of episodic memory impairments in negative symptoms is important because they are a 
potential treatment target in an area with very few evidence-based interventions and a 
large unmet need. The target outcomes of this intervention study were important 
components of negative symptoms previously identified and used in similar previous 
studies:  positive affect, negative affect, motivation and anticipatory pleasure (Edwards et 
al., 2015a; Painter & Kring, 2016; Sanchez, Lavaysse, Starr, & Gard, 2014). A measure of 
self-efficacy was added as a novel outcome measure as this has recently been highlighted 
as a potential causal mechanism in negative symptoms and poor functioning (Campellone, 
Sanchez, & Kring, 2016; Staring, Ter Huurne, & van der Gaag, 2013). 
The overall aim of this research is to investigate the role of impaired 






with schizophrenia. First, in Study 1 cross sectional associations were examined using the 
most valid measures of these constructs. Negative symptoms were assessed using the 
Clinical Assessment Interview for Negative Symptoms (CAINS) which incorporates an 
experiential and expressive subscale allowing these to be considered separately. Important 
potential confounders highlighted in the literature such as depression, working memory 
and defeatist beliefs were also assessed.  Second, in Study 2 a brief novel intervention was 
piloted to test the feasibility of using autobiographical memory to target motivation, self-
efficacy and anticipatory pleasure in people with psychosis. This study further explored the 
potential causal mechanism of autobiographical episodic memory retrieval in negative 
symptoms.  
Research Questions and Hypotheses 
The research questions for Study 1 are as follows:  
1. Is reduced autobiographical memory specificity associated with higher levels of 
experiential negative symptoms and lower functioning? 
2. Are these relationships moderated by depressive symptoms or cognition? 
Study 1 Hypotheses 
3. People with psychosis will generate valid positive and negative valence 
autobiographical memories.  
4. The negative memories generated will have reduced specificity compared to 
positive memories.  
5. Autobiographical memory will be associated with experiential negative symptoms, 
verbal fluency, working memory, functioning and depression.  
The research questions for Study 2 are as follows:  
1. Is a brief novel intervention designed to enhance retrieval of a positive 






2. Does a pilot intervention designed to enhance retrieval of a positive autobiographical 
memory show evidence of a subsequent improvement in a state assessment of 
experiential negative symptoms and functioning (i.e. mood, motivation, self-efficacy 
and anticipatory pleasure for a possible future event) and what are the preliminary 
estimates of effect sizes and confidence Intervals of any potential changes? 
 
Study 2 Exploratory Aims:  
a. The intervention will be feasible to deliver, and the following information will be 
reported to assess this: rates of referral, participants meeting eligibility criteria, 
consent rates and therapy adherence. 
b. Participants will generate appropriate activities and linked memories and the nature of 
these will be reported.  
Study 2 Hypotheses: 
c. Participants will generate vivid, positive memories in both conditions, but these will be 
rated as more pleasant and real in the guided recall condition.  
d. Participants will rate the intervention as acceptable and helpful - rated as 80% or 
higher on these scales in the evaluative questionnaire.    
Methods 
Study Outline  
This project is divided into two sub-studies to address the research questions. The first 
study is a cross-sectional study and the second is a pilot intervention study. The 
inclusion/exclusion criteria for the sample (who participated in both studies) and the power 
calculations conducted to determine the number of participants required are described in 
this section. The measures used, and the development of the therapeutic intervention are 
outlined and the analysis plan is presented. All research procedures employed in this thesis 
received ethical approval from the London – Camberwell St Giles Research Ethics 






conducted in the NHS, all relevant documents are included in the Appendix. The protocol 
for this study was also published on clinicaltrials.gov.uk.  
Study Design  
A sample was recruited to participate in both studies. Study 1 had a cross-sectional design 
with the aim of examining hypothesised relationships between autobiographical memory 
and experiential negative symptoms. Study 2 had an experimental design with the aim of 
assessing feasibility and deriving preliminary estimates of effects, and the participants were 
randomized to either the intervention or control condition with a randomisation ratio of 
2:1. This ratio was selected to maximise the information gathered about the intervention 
and avoid significant loss of power from drop-out in the intervention condition (Dumville, 
Hahn, Miles, & Torgerson, 2006).  
Sample 
Participants were recruited from inpatient and community psychosis services across South 
London and Maudsley NHS Trust.  
Inclusion Criteria  
• Diagnosis of non-affective psychosis (as determined by medical records).  
• Aged 18 - 65yrs  
• Sufficient English language to participate in the research.  
Exclusion Criteria  
• Lack of capacity to provide informed consent to take part in the study.  
• Primary diagnosis of intellectual disability, head injury, substance misuse or known 
organic cause of psychosis.  
Recruitment Procedure  
Participants were recruited through their clinical team.  The participant was first 
approached by a member of their care team to introduce the study. If they indicated that 
they were willing to consider the project and gave verbal consent for the researcher to 






information sheet and consent form). The researcher then contacted them again after at 
least 24 hours to discuss their potential participation.  
Participants were reimbursed £15 for their participation in the cross-sectional study and 
£10 for their time in the intervention session.  
Power Analyses  
A power analysis was conducted in GPower Software Version 3.1 (Faul, Erdfelder, Lang, & 
Buchner, 2007). Power was set at 0.8, α = 0.05 and the analysis was conducted for a two-
tailed hypothesis due to limited literature reporting an association in one direction. These 
criteria are in line with the parameters set in the field of psychology research (Field, 2009). 
The power calculation was conducted for Study 1 and found a sample size of 32 would be 
sufficient to replicate a correlation with a medium effect size of 0.43 reported between 
memory specificity and negative symptoms by Harrison and Fowler (2004). Study 2, as a 
feasibility study, was not powered for significance testing of effects, but the sample size for 
study 1 was deemed to be suitable for examining feasibility outcomes. 
Measures  
The measures are all included in the Appendix.  
Study 1: Cross-Sectional Study  
Autobiographical Memory Test (AMT) (Williams & Broadbent, 1986) 
This task presents participants with cue words and asks them to generate specific 
autobiographical memories in response. An example is usually given by the experimenter 
as part of the instructions and participants complete at least one practice trial and receive 
feedback. In previous studies using this task the memories generated are coded by the 
experimenter (Dritschel, Beltosis, & McClintock, 2014). Some studies have also asked 
participants to rate their experience of recalling the memory (D'Argembeau & Van der 
Linden, 2004). A recent study adapted the AMT to incorporate both interviewer and 
participants ratings of the memory (Painter & Kring, 2016) and this version was used in 






shown to be valid and reliable in this population when using general prompts (e.g. 
positive/negative events) as well as more specific prompts (e.g. fairground) (Berna, 
Potheegadoo, et al., 2016; Painter & Kring, 2016). It has been shown that specific cues 
considered to be positive or negative when used in control populations can result in 
different emotional responses from people with psychosis (Edwards, Cella, Tarrier, & 
Wykes, 2015b). Therefore, it was considered important to provide general prompts for this 
task and give the individual flexibility to choose memories that they identified as positive or 
negative. Shortened versions of this task have also been shown to be robust and this was 
an important consideration when designing the burden of the assessment session on 
participants.  
Participants were asked to generate a narrative for an event that occurred in the past at a 
specific time and place and did not last longer than one day. They were asked to do this for 
2 separate events, one positive and one negative. The participants completed one practice 
trial where they were asked to generate a narrative for a time when “they listened to music 
or the radio”. The participant was given feedback on this practice trial (e.g. “Exactly, now 
do the same for the rest of the narratives”, or “Good, but for the rest of the task please tell 
me about an event that occurred at a specific time or place”) and then begin the memory 
task. For each cue the participant was prompted as follows: “Picture a specific time in the 
past when a [positive or negative] event occurred. Tell me about it in as much detail as 
possible, as if you were telling a story.” 
Participant Ratings  
The participants then completed a questionnaire relating to the memory to assess how 
detailed they found the experience and how positive or negative they found the memory to 
be (see Appendix X). This questionnaire used visual analogue scales with anchors at 0, 50 






Interviewer Ratings  
The researcher then rated the memory on the following areas:  
• Time/place specificity 
• Sociality 
• Elaborative detail  
• Clarity  
• Emotional content  
 
These ratings are broadly in line with those adopted in the Painter and Kring (2016) study 
with the addition of a rating for emotional content which was considered important due to 
the evidence that this may be limited in people with psychosis (Herbener, 2008). Of these 
memories, 10% (n = 8) were coded by an independent researcher and were found to have 
excellent reliability (ICC = .96, 95% CIs = .82 - .99).  
Verbal Fluency Test (Lezak, Howieson, Bigler, & Tranel, 2012) 
The FAS and categories subtests from this task aim to assess verbal fluency. Participants are 
asked to generate as many words (not proper nouns) as they can which start with a certain 
letter (F, A and S) and then do the same for categories of words (e.g. animals) over the 
period of 1 minute. It has been shown to be a valid and reliable measure in psychosis 
(Joyce, Collinson, & Crichton, 2009). The evidence suggests that people with non-affective 
psychosis have difficulties with generation and fluency (Henry & Crawford, 2005) and this 
might impact on their ability to communicate their memories despite recalling them.  
Letter-Number Sequencing (Wechsler, 2011)  
This task involves remembering groups of numbers and letters following one verbal 
presentation and then repeating them back to the examiner, numbers first in numerical 






valid brief assessment of working memory which again is an area where people with 
psychosis have been shown to have difficulty (Lee & Park, 2005). This may also compromise 
their ability to present an autobiographical memory narrative and therefore it is included 
as a potential moderator.  
Beck Depression Inventory (Beck, Steer, & Brown, 1996)   
This 21-item self-report scale, rated on a 4-point scale from 0 – 3 (total score ranges from 0 
to 63, >13 indicates a clinically-relevant level of depression) was used to assess depression 
severity.  In the meta-analysis findings reported in this thesis and in the wider literature the 
BDI has been identified as a reliable measure in people with psychosis e.g. (Chemerinski et 
al., 2008).   
Defeatist Performance Beliefs - Dysfunctional Attitudes Scale (Weissman & Beck, 1978) 
This 15-item subscale was included as an assessment of defeatist beliefs. Each item consists 
of a statement and a 7-point Likert scale (1 = fully disagree to 7 = fully agree). The total 
score ranges from 15 – 105 with higher scores indicating more defeatist beliefs. This scale 
has been used extensively in people with psychosis and has been shown to be reliable and 
valid (Campellone et al., 2016; Grant & Beck, 2009).  
Clinical Assessment Interview for Negative Symptoms (Kring et al., 2013)  
This recently developed interview assesses negative symptoms in schizophrenia. It has two 
negative symptom factors: experiential and expressive. Each item is scored from 0 = no 
impairment to 4 = severe deficit.  An experiential item requires asking the participant 
questions such as “Have you spent much time with your family in the last week?” and “Is 
having a relationship with your family important to you?” Motivation for family 
relationships is rated according to answers to these and further questions. The interview 
then asks how many pleasurable social activities have occurred in the last week and how 
many are expected next week. These two answers are used to rate the current and 






interviewer based on their observations during the assessment e.g. facial expression, vocal 
expression. CE was trained in conducting the CAINS interview by a researcher on a clinical 
trial using observations of previous recorded interviews. The subscales have good internal 
consistency, as does the complete measure which has been shown to be reliable and valid 
(Kring et al., 2013).  
Time Use Survey (Hodgekins et al., 2015) 
The Time Use Survey is administered in an interview format. It provides a measure of 
functioning by assessing how much time is spent on a range of activities. It produces two 
scores in hours per week: one for Constructive Economic Activity (CEA) and one for 
Structured Activity (SA). The CEA score includes time spent in employment, studying, 
housework, childcare and looking for work or education. The SA score includes the CEA 
score plus more recreational activities such as hobbies and socialising. The Time Use Survey 
provides information on activities completed and time spent in a wide range of domains 
including leisure and work/study. This is an advantage over other performance-based 
assessments or questionnaires that ask for frequency but not duration of activities. The 
Time Use Survey has been extensively validated in the UK general population (Gershuny, 
2011; Lader, Short, & Gershuny, 2006) and in people with a diagnosis of schizophrenia 
(Fowler et al., 2009; Hodgekins et al., 2015). 
The Scale for the Assessment of Positive Symptoms (Andreasen, 1984) 
This scale was used as a measure of positive symptom severity, each item is rated from 0 
(absent) to 5 (severe). Two subscales; hallucinations (7 items) and delusions (13 items) 
were assessed. CE was trained in conducting the SAPS by one of the research supervisors 
who has a wealth of experience using the measure. The SAPS has been shown to be a 
reliable and valid measure of these symptoms in psychosis and has been used in multiple 






Study 2: Pilot Feasibility Study  
Acceptability and Feasibility Outcomes  
The number of participants referred to the study is reported as an indicator of appropriate 
referrals. The completion rates of individuals taking part in the session is also recorded to 
assess the adherence to the protocol. The ability of participants to generate activities for 
discussion in the session and associated positive memories are reported. The categories of 
activity selected by participants is reported.   
Intervention Feedback Questionnaire 
A feedback questionnaire which utilised the same visual analogue scales (0-100) was given 
to the participants in both the basic recall and guided recall conditions to gather their 
feedback on their experience of taking part. Questions with space for participants to 
provide written feedback were also included in this questionnaire. The findings from this 
questionnaire were used to assess the acceptability of the intervention and evaluate the 
service user experience.  
Pre- and Post-Intervention Measure  
A measure was developed based on “in the moment” assessments of mood, motivation, 
anticipatory pleasure and self-efficacy that have been used in previous experience sampling 
studies (Edwards, Cella, Tarrier, & Wykes, 2016; Oorschot et al., 2013). These areas were 
included as they are hypothesised to be the areas where change may be seen as a result of 
the intervention based on previous studies (Ricarte et al., 2012). Visual analogue scales 
were used with anchor points at 0, 50 and 100 and participants were asked to place a cross 
on the line to mark their response.   
Intervention Condition: Guided Recall  
Participants were shown a psychoeducation video developed for this study which presents 
three stories with examples of how memory impacted on motivation to engage in certain 
activities. This was paused at various points and the issues raised by the video were 






to do in the future that they have positive memories of doing in the past. The participant 
then recalled a memory of a time when they did the activity being discussed and the 
researcher supported this recall with prompts taken from previous autobiographical 
memory studies (Ricarte et al., 2012) and the Memflex intervention for autobiographical 
memory (Hitchcock et al., 2017). These prompts covered the following areas:  
- Details – who/what/where/when 
- Five senses – smell/taste/hear/see/touch 
- Identity – what does this tell us about you as a person? 
- Positive themes – what was good about this event for you? 
- Generalisation of positive themes – does this link to other activities you have done? 
How? 
- Future planning – what steps could you take to repeat this activity? 
Control Condition: Basic Recall   
In the control condition participants are not shown the psychoeducation video and do not 
receive additional prompts during the memory recall. Participants in this condition began 
by choosing two activities they have done previously that they would like to do again in the 
future. They then recalled a memory of doing each activity (with no prompts).   
Study Procedure  
Study 1: Cross-Sectional Study 
The participant was given 24hrs to consider the information sheet prior to meeting with 
the researcher. The researcher then gave them time to consider the information and ask 
questions at the start of the meeting. Informed consent was then gained from the 
participant. The measures were completed in the order they are presented above. The 
session lasted between 1hr and 1.5hrs, some participants completed this in two parts, but 






Participants were then randomised (2:1 ratio) using the secure online program 
www.sealedenvelope.com.  
Study 2: Intervention Pilot Study  
Intervention Condition: Guided Recall  
Participants completed the pre-intervention measure then watched the psychoeducation 
video. Guided recall took place following identification of an activity and linked memory. 
The post-intervention questionnaire was then completed. This protocol was repeated for 
the second activity (the video was not repeated) and participants then completed the 
feedback questionnaire.  
Control Condition: Basic Recall  
Participants completed the pre-intervention measure then identified an activity and linked 
memory. They recalled this memory with no additional prompts then completed the post-
intervention questionnaire. This protocol was repeated for the second activity and then the 
feedback questionnaire was completed.  
Analyses  
Data Quality 
All ratings were examined for normality using Shapiro-Wilks tests and visual inspection of 
Q-Q plots (Ghasemi & Zahediasl, 2012). Where normality was confirmed parametric tests 
were conducted. Variables not normally distributed were logarithmically transformed 
(Lg10) and normality analyses repeated. If data were still not normally distributed non-
parametric tests were conducted on the non-transformed data. Data were examined for 
outliers that were over +/- 2 standard deviations from the mean. Analyses were repeated 
with these outlying data-points excluded (Tabachnick, 2013). The significance level 
threshold was set at p = <0.05. All tests conducted were 2-tailed (Field, 2009). Analyses 







The demographics of the participants are presented for both studies. The groups are 
compared on these variables using chi-squared tests for categorical variables e.g. ethnicity, 
and t-tests for continuous variables e.g. age. The mean and distribution of the scores on 
the scales used were also reported. 
Cross- Sectional Study  
Memory Ratings   
The memories provided during the autobiographical memory test were rated both by the 
researcher and the participant. The ratings generated by the participants were compared 
between positive and negative memories using paired t-tests to establish the validity of the 
memories generated.  
Correlational Analyses  
Correlational analyses were conducted to test the hypothesised relationships between 
autobiographical memory specificity and negative symptoms, cognitive measures, 
depression, defeatist beliefs and functioning. If there was indication that confounding may 
be present, partial correlations were conducted with the indicated variables.  
Intervention Study 
Feasibility and Acceptability  
This is a pilot study of a novel intervention and both eligibility of referrals to the study, 
consent rates and adherence rates were reported as a measure of feasibility. The 
categories of activities selected by participants were presented to provide an idea of the 
feasibility and focus of the sessions. The ratings of pleasantness and “realness” of the 
memories completed by participants after each recall were reported and compared 
between groups to ensure vivid positive memories were generated in both conditions and 
to examine the impact of additional prompts on the experience. To fully report the 






participants was summarised and presented for both groups. Quotes from participants in 
response to open questions on the feedback questionnaire were reported.  
Pilot Efficacy  
This pilot study enabled exploratory analyses regarding whether state assessments of 
mood, motivation, anticipatory pleasure and self-efficacy were improved by the guided 
recall condition compared with the basic recall condition. These ratings were combined 
into pre- and post across the two activities. A between-group standardised effect size 
(Cohen’s d) was calculated for each of these variables using the post-means for each group 
and the pooled, baseline standard deviation. The 95% confidence intervals for the effect 
sizes are reported.  
Results  
Study 1: Is there a relationship between autobiographical memory and negative 
symptoms in people with non-affective psychosis? 
Sample  
A total of 34 people with a diagnosis of non-affective psychosis took part in the study. Of 
these, 64.7% were inpatients at the time they took part in the study, including 6 in a 
rehabilitation ward and 14 in an acute ward setting. Thirty-two participants (94%) were 
currently prescribed antipsychotic medication, with 12 on depot injections. The full 
characteristics of the sample are described in Table 1 below.  
The mean score on the BDI reflects a mild level of depression in the sample which 
replicates previous studies (Chemerinski et al., 2008). Verbal fluency scores are similar to 
those reported in other studies e.g. 44.76 (Joyce et al., 2009). Letter-number sequencing 
was slightly lower than previous studies (e.g. 9.18, SD = 2.55) suggesting poorer working 
memory on average in the sample (Horan et al., 2008). The CAINS total score was similar to 






higher experiential (e.g. 14.94, SD = 4.91) and lower expressive subscale totals (e.g. 4.91, 
SD = 3.19) (Painter & Kring, 2016; Strauss & Gold, 2016). Low positive symptom scores are 
also common in studies focused on negative symptoms e.g. (Edwards et al., 2015b; Forbes 
et al., 2010). The Time Use scores for both CEA and SA are significantly lower than in a 
recent large-scale study (CEA = 19.46, SA = 48.37) suggesting reduced functioning in this 
sample (Cella, Edwards, & Wykes, 2016). The defeatist performance beliefs score is 
elevated and in line with previous studies in this population e.g. 47.3 – 53.3 (Granholm, 
Holden, Link, McQuaid, & Jeste, 2013; Grant, Perivoliotis, Luther, Bredemeier, & Beck, 
2017).  
Table 1: Sample Characteristics (n = 34) 
 
 Mean/Percentage Standard 
Deviation  
Range  
Age  39.1 10.99 23-59 
Gender (%M) 76.5   







Ethnicity (%) White British: 17.6 
Black British: 50.0 
Black African: 17.6 
Hispanic: 2.9 
Black Caribbean: 8.8 
White European: 2.9  
  
Primary Diagnosis (%) Non-Organic Psychosis: 17.6 
Schizoaffective Disorder: 17.6 
Schizophrenia: 58.8 
Delusional Disorder: 2.9 
Organic Catatonic Disorder: 2.9 
  
BDI (Total) 14.65  13.78 0-52 








5.56 2.68 2-12 
CAINS  Total: 21.94  

















Time Use  Constructive Economic Activity: 7.01 




1.8 – 74.38 
Defeatist Performance 
Beliefs Subscale - 
Dysfunctional Attitudes 
Scale (Total) 
51.56 16.72 21-93 
 
Data Quality 
All continuous variables included in further analyses were examined using a Shapiro-Wilks 
Test and examination of Q-Q plots. All questionnaire data were normally distributed. The 
verbal fluency test showed significant skewness due to one outlier who scored highly, 
repeating these analyses without this data point did not alter the conclusions below. The 
external memory ratings were normally distributed. The self-ratings of details for both 
positive and negative memories were skewed by two outliers (different for each memory 
type). Excluding these outliers and repeating the paired t-test conducted did not alter the 
conclusions below. Intensity and emotion ratings were normally distributed.  
Do People with Non-Affective Psychosis Generate Valid Autobiographical Memories?  
Participants were able to generate valid positive and negative memories. This is 
determined by positive memories being rated as containing more positive emotion than 
negative memories and vice versa for negative emotion (see Table 2). The positive and 
negative memories did not differ on the detail as rated by participants or interviewers. 







Table 2: Characteristics of Autobiographical Memories 
 Negative Memory Positive Memory Comparison (paired t-test) 








40.64 39.09 88.05 16.97 6.78 .000 
Intensity 
(Sum of 2 
ratings,  
0-200) 
119.55 60.24 141.42 53.50 -2.59 .01 
Details (Sum 
of 7 ratings,  
0-700) 
409.28 146.99 453.35 137.25 1.41 .17 
Interviewer 
Ratings (Sum 
of 5 ratings,  
0-10) 
5.76 2.19 5.71 2.35 .14 .89 
 
Correlational Analyses 
The correlational analyses showed that, in contrast to our hypotheses, depressive and 
negative symptoms did not correlate with the interviewer ratings of autobiographical 
memory. The one exception is expressive negative symptoms which was weakly correlated 
with negative memory ratings (see Table 3 below). Increased structured activity was 
moderately associated with reduced experiential negative symptoms and increased 
positive memory ratings. In line with our hypotheses, cognitive abilities correlated with 
memory ratings and functioning. Increased defeatist performance beliefs were weakly 






Table 3: Correlational Analyses 













Time Use CEA  .63** -.08 -.07 .08 .01 .51** .36** -.10 -.17 
Time Use SA .63**  .02 -.13 -.44* -.01 .62** .05 .08 .42* 
BDI -.08 .02  .22 .09 .04 .23 .17 .10 .20 
DPA-DAS -.07 -.13 .22  .28 .17 -.17 -.24 -.21 -.37* 
CAINS MAP .08 -.44* .09 .28  .21 -.33 -.32 -.16 -.28 
CAINS 
Expressive 
.01 -.01 .04 .17 .21  -.34 -.22 -.36* -.14 
Verbal 
Fluency 












-.17 .42* .20 -.37* -.28 -.14 .30 .46** .38*  






Study 2: Acceptability and Feasibility of a Brief Autobiographical Memory Intervention for 
Low Motivation in Psychosis  
 
Sample 
The total recruited was 34 participants who were randomised in a ratio of 2:1 to a guided recall 
or basic recall condition. A total of 21 people completed the guided recall condition of the 
study (3 lost to follow up), A total of 10 people completed the basic recall condition of the 
study (0 lost to follow up). The full characteristics of the two samples are described in Table 4 
below. There were no significant differences between the groups except for negative 
symptoms, which were higher in the guided recall condition.  
Table 4: Characteristics of Guided Recall and Basic Recall Conditions 
 Guided Recall Condition (n = 21) Basic Recall Condition (n = 10) 
Mean Age (SD) 38.62 (10.98) 41.10 (9.09) 
Gender (%M) 76.2 80 








Ethnicity (%) White British: 9.5 
Black British: 61.9 
Black African: 19 
Hispanic: 0 
Black Caribbean: 9.5 
White European: 0 
White British: 30 
Black British: 40 
Black African: 0 
Hispanic: 10 
Black Caribbean: 10 
White European: 10 
Primary Diagnosis (%) Non-Organic Psychosis: 14.3 
Schizoaffective Disorder: 14.3 
Schizophrenia: 61.9 
Delusional Disorder: 4.8 
Organic Catatonic Disorder: 4.8 
Non-Organic Psychosis: 20 
Schizoaffective Disorder: 20.0 
Schizophrenia: 60.0 
Delusional Disorder: 0 
Organic Catatonic Disorder: 0 






Verbal Fluency Total 53.05 (15.07) 61.80 (28.81) 
Letter-Number Sequencing Total 5.10 (2.81) 6.44 (2.55) 
CAINS Total 24.1 (6.37) 17.1 (6.82) 
SAPS Total 6.95 (10.20) 9.60 (10.21) 
Time Use Structured Activity  23.52 (25.40) 31.81 (24.98) 
 
Acceptability and Feasibility  
Referrals 
41 people were referred to the study, 2 of these people were not eligible as they had a 
diagnosis of Bipolar Affective Disorder. Of the remaining 39 people, 4 people did not consent 
to take part when approached, the remaining 35 people (90%) provided informed consent to 
take part in the study.  
Were participants adherent to the guided recall intervention? 
All participants except for 2 took part in the complete session which lasted 40mins – 1 hour. 
These included one participant in the guided recall condition who declined to watch the video 
and was not able to give a reason for this but completed both memory exercises. The other 
participant who was not able to complete the enhanced recall session was not able to 
concentrate adequately on the video and only completed one memory exercise, he attributed 
this to sedative effects of a recent medication increase. 
Were participants able to select appropriate activities for the session? 
Participants in both conditions selected a wide range of activities, which have been 
summarised in Table 5 below. Examples of hobbies identified more than once include: listening 








Table 5: Activity Selection in Both Conditions 
Activity Type  Activity 1 N (%) Activity 2 N (%) 
Creative 1 (3.3) 2 (6.9) 
Employment 4 (13.3) 0 
Education 1 (3.3) 3 (10.3) 
Exercise 8 (26.7) 8 (27.6) 
Social 6 (20.0) 1 (3.4) 
Hobbies 10 (33.3) 15 (51.7) 
 
Were participants able to generate positive memories linked to those activities? 
It was demonstrated in the findings of Study 1 that the participants were able to generate valid 
positive autobiographical memories. The additional requirement of linking these to activities 
was met by the participants and the “pleasantness” ratings below demonstrate that these 
memories were also positive. Participants rated memories in both conditions highly on a scale 
which asked them how “real” they felt during the recall. There were no significant differences 
in the ratings of either pleasantness or “realness” in the two conditions but pleasantness is 
elevated in the guided recall condition.  
Table 6: Pleasantness and Vividness Ratings After Memory 1 and Memory 2 in Both Groups 
 Guided Recall Condition  Basic Recall Condition  Comparison 
(t) 
Memory 1 Post-Pleasant  
(-10 - 10) 
6.70 (4.15) 6 (4.44) .42 
Memory 1 Post-Real  
(0-100) 
78.97 (23.74) 80.27 (25.24) -.14 
Memory 2 Post- Pleasant  
(-10 – 10) 
6.95 (3.98) 5.81 (4.32) .71 
Memory 2 Post- Real  
(0-100) 







Did participants find the interventions acceptable? 
Participants across both conditions rated the interventions as highly acceptable (>80%). These 
ratings were not significantly different between groups suggesting that participants found the 
basic recall condition sufficient to learn something from the session and find it helpful.  
 
Table 7: Summary of Items on Feedback Questionnaire in Both Groups 
Acceptability Item Guided Recall Condition Basic Recall Condition  t statistic  
Helpful (0-100) 82.80 (17.37) 83.78 (20.46) -0.14 
Easy (0-100) 83.84 (19.42) 86.16 (17.12) -0.32 
Learned Something (0-
100) 
86.13 (16.05) 87.28 (16.67) -0.18 
Relevant  (0-100) 77.45 (18.92) 82.16 (19.64) -0.64 
Recommend to Others (0-
100) 
79.56 (20.64) 83.90 (20.49) -0.55 
Take Part in Something 
Similar (0-100) 
83.31 (17.73) 86.04 (17.12) -0.402 
 
What did participants say about the intervention? 
The participants in both conditions provided a lot of feedback regarding their experience of 
taking part in the sessions. Ideas that were reported as helpful by participants were practicing 
recall of happy memories and the link between memory and motivation. Some suggestions for 
improvements included ensuring a calm environment, perhaps adding some music to enhance 










Table 8: Summary of Qualitative Feedback Provided 
Guided Recall Condition Basic Recall Condition 
What was most helpful about the session? 
 
Focusing on decision-making, overcoming 
negativity. Narrators in the video were helpful. 
recounting my memories 
Gaining new perspective on how memories and 
actions are interlinked. Freedom in recalling 
sesnsations and feelings for application in everyday 
life. 
Remembering that I need to pay more attention to things 
Having someone to talk to about my experiences Scales of percentage. Completing them twice. Talking 
about them. 
It made me think about positive activities that help my 
general wellbeing and attitude 
The fact that we talked about doing things 
It was a way of looking into certain areas that enabled 
me to appreciate life events, make changes, think more 
in depth about them and to learn 
The idea that memories can boost motivation and 
reminding myself of happier times 
Jogged my memory and had some pleasant feelings 
thinking about good times in the past that can happen 
again 
The memory task, i.e. thinking about things unusual to 
me 
Learning new things and skills Thinking of memories 
Makes me open up, remembered things I forgot to tell 
care co-ordinator 
 
Remind - compromise in the futue. Something to keep 
and work at for the future. 
 
Talking about the gallery. The video was good - other 
people with low confidence - it's not just me 
 
Talking and expressing my feelings  
Talking to [Researcher]. Motivation  
To remember events from the past  
Video  
What was least helpful about the session? 
 
Medication sometimes interfered. In comparison to if I 
weren't on them (few pains) 
More memory related games could be fun and boost 
confident and intellect 
Remember sad times No space to write down details. 
Still images of a person with the images above their 
head - couldn't see very well - no glasses. More 







 Time taken 
Will you continue using anything from the session? 
 
Ask about pool, try and find other things I can go with 
the flow. Go to art gallery. 
Build from the memories of talking about my activities 
Making more memorable moments. No 
The way pleasant memories can lead to positive 
attitudes towards life 
recalling happier times to help motivate and build 
happiness 
Think about my career in the computers remain positive about the experience 
try to recognise, the good things in my life, rather than 
being depressed. 
Yes 
Yeah Yes, I will  
YES I will  
YES memory disadvantage of good and bad memories. 
 
 
Is there anything you would change about the session? 
 
Not really it's natural More memory related tasks and games. maybe some 
meditation/mindfulness on happy memories. 
Not sure To see first ratings from the first time. 
nothing  
Nothing  
Nothing really  
Calming background music, quieter environment, 
providing less distraction from tasks at hand. 
 
Any other comments? 
 
Repetition is helpful. I hope the research goes well. 
The session has been helpful I would be happy to attend another study. 
 I would like the memory task to be done in the second 
session so that I can see how my memory has improved 







Preliminary Estimates of the Efficacy of Pilot Intervention  
As the intervention was repeated for two activities during the session the pre- and post-ratings 
(negative mood, positive mood, motivation, self-efficacy and anticipatory pleasure) were 
combined across the two memories. The mean values and effect sizes for each variable at the 
pre- and post- time points in each group are reported in Table 9 below. The mean value for the 
basic group was subtracted from the guided group and therefore a positive value indicates 
greater improvement in the condition with more prompts. The exception is negative mood 
where a negative value would indicate the negative mood had been reduced further in the 
guided group. These standardised effect sizes indicate effects in the expected directions for 
motivation, self-efficacy and negative mood – although these are small-moderate with wide 
confidence intervals. The effect size for anticipatory pleasure does not signal a clear direction 
for this effect and whilst the descriptive data indicate increased and stable positive mood in 
the guided and basic groups respectively, the effect size is in the opposite direction to 















Table 9: Pre- and Post-Means for Both Groups 











Guided Pre 77.53 4.16 69.21 85.86 
0.32 (-.21, .86) 
Post 81.01 4.15 72.80 89.40 
Basic Pre 76.75 5.81 65.12 88.38 




Guided Pre 85.94 3.29 79.34 92.54 
-.05 (-.59, .48) 
Post 84.35 3.05 78.23 90.47 
Basic Pre 82.40 5.14 72.09 92.70 
Post 86.58 4.76 77.03 96.13 
Self-Efficacy 
(0-100) 
Guided Pre 73.06 4.20 64.64 81.49 
.19 (-.34, .73) 
Post 74.07 4.27 65.50 82.64 
Basic Pre 73.50 6.56 60.34 86.65 
Post 70.85 6.67 57.47 84.23 
Positive 
Mood (0-300) 
Guided Pre 161.26 9.04 143.04 179.49 
-.34 (-.91, .24) 
Post 178.95 8.50 161.80 196.10 
Basic Pre 202.12 16.33 167.32 236.93 
Post 198.11 15.46 165.15 231.07 
Negative 
Mood (0-400) 
Guided Pre 131.89 12.18 107.33 156.45 
.20 (-.36, .76) 
Post 116.62 11.76 92.90 140.34 
Basic Pre 123.58 23.26 74.00 173.16 








Summary of Key Findings 
The results of the autobiographical memory task in Study 1 showed that people with non-
affective psychosis were able to generate valid positive and negative autobiographical 
memories with the expected emotional ratings. There was no evidence of over-general 
memory for either category. Positive memories were rated as a more intense emotional 
experience than negative memories.  
Our hypotheses that negative and depressive symptoms would be associated with 
autobiographical memory ratings were not supported. The one exception was for expressive 
negative symptoms which were associated with less detailed negative memories only.  As 
expected, working memory performance was linked to less detailed negative and positive 
memories, this was not the case for verbal fluency. More detailed positive memories were 
associated with fewer self-defeatist beliefs and increased structured activity.  
Participants were able to complete the intervention sessions as planned in Study 2 and 
identified appropriate activities to discuss, with hobbies and exercise the most common 
categories. Similarly, to Study 1, participants were able to generate memories linked to these 
activities that they rated as having high levels of positive emotion, this was the same for both 
groups. Participants overwhelmingly rated both conditions as acceptable and helpful with the 
feedback suggesting that participants found the concept of link between memory and 
motivation relevant and helpful. There was no evidence of an anticipatory pleasure deficit, 
with both groups reporting high levels at the start of the session. The findings are encouraging 
for future interventions using guided autobiographical memory retrieval with effects in the 






Autobiographical Memory as a Therapeutic Target in Non-Affective Psychosis  
Study 1: Cross-Sectional Findings 
Autobiographical memory specificity does not appear to be linked consistently to negative or 
depressive symptoms in psychosis, with the null finding from this study adding to mixed 
findings in the wider literature (Berna, Potheegadoo, et al., 2016). This may be due to high 
variation in measurement of all three constructs; negative symptoms, depressive symptoms 
and memory specificity. However, it could also represent the heterogeneity which is emerging 
across the presentation of negative and depressive symptoms in people with psychosis. This 
may mean that autobiographical memory is linked to these symptom dimensions in certain 
subgroups which are yet to be identified consistently. An important finding is that expressive 
symptoms seem to limit the ability to generate rich negative memories only. Due to the cross-
sectional nature of this study it is not clear in which direction this association may occur. Over-
general negative memory can contribute to low mood as has been documented in the 
depression literature (Williams et al., 2007). However, people who have vague memories for 
negative events may also express less emotion in general and this could contribute to high 
levels of expressive negative symptoms. It is also important to note that the failure to confirm 
our hypothesis regarding the link between experiential negative symptoms and 
autobiographical memory limits the use of the causal-interventionist approach. However, the 
links found between positive autobiographical memories and both lower functioning and self-
efficacy beliefs provide support for exploring an intervention targeting this area. 
As has been documented in other studies (Painter & Kring, 2016) this study found that people 
with psychosis generate high levels of positive and negative emotion and can do so 
appropriately for memories as well as “in the moment” stimuli (Yan et al., 2012). Positive 






why expressive deficits were linked to negative memory ratings only. If positive memories are 
more intense as rated by the individual, then the interviewer ratings are perhaps less likely to 
be limited by expressive deficits. Only positive memories were associated with functioning, 
those individuals with richer positive autobiographical memories reported doing more 
“Structured Activity” and endorsed fewer self-defeatist beliefs. Again, the cross-sectional 
design does not allow us to establish the direction of this association. It may be that richer 
positive memories enable the individual to engage in more activity and provide evidence to 
support self-efficacy beliefs. Alternatively, individuals who are doing more could be having 
more positive experiences and therefore find these memories easier to access in detail. People 
with fewer defeatist beliefs might also find it easier to see the value in activities they have 
engaged with in the past and therefore report them in more detail. These hypotheses all fit 
with a cognitive perspective which proposes that low expectations (social rejection, stigma and 
performance) contribute to negative symptoms (Conway & Pleydell-Pearce, 2000; Rector, 
Beck, & Stolar, 2005). Studies with a longitudinal or experimental design which disentangle the 
direction of this association are needed.  
The findings from Study 1 present some initial evidence to add to this growing field which 
suggests that rich autobiographical memories are available as a therapeutic target in people 
with non-affective psychosis. This adds to the substantial body of evidence that people with 
psychosis have intense emotional experiences despite expressive deficits. There is some 
suggestion that targeting positive memories may positively impact on functioning and reduce 
unhelpful self-defeatist cognitions which are associated with negative symptoms (Campellone 






Study 2: Feasibility and Acceptability of a Pilot Intervention  
The people who were referred to the study met the eligibility criteria, however inclusion of 
people with Bipolar Disorder could be considered in future research. The high rates of people 
who completed Study 2, in both guided and basic recall conditions, suggests memory 
interventions are feasible to deliver in this population. The findings regarding the engagement 
in the session show that people with psychosis can engage successfully in an intervention 
which targets autobiographical memory linked to positive activities and their future goals. 
Participants in both a basic and guided recall condition found this an acceptable intervention to 
take part in and provided positive feedback.  
The positive signals for self-efficacy and motivation are encouraging for future interventions in 
the field of negative symptoms. This replicates findings from a study using additional prompts 
to support work on a cognitive task – participants in the guided condition endorsed fewer self-
defeatist beliefs following the intervention (Grant et al., 2017). Follow-up as to how this 
impacts on engaging with activity is important to establish the real-world significance of this 
finding. To add to the current debate in the field, there was no evidence of an anticipatory 
pleasure deficit with both groups rating this highly at the start of the session. Anticipatory 
pleasure did not appear to be a useful outcome in this intervention with the signal showing no 
clear direction of effect. This is perhaps unsurprising in a field with very mixed outcomes 
regarding anticipatory pleasure (Edwards et al., 2015a). Motivation and self-efficacy may be 
more useful outcomes to focus on in future clinical research.  
It is important to note that positive mood does increase in the guided group, and both groups 
retrieved positive autobiographical memories as part of the intervention received – supporting 
further investigation of this technique in therapeutic work. Negative mood did show an effect 






from negative emotions they may be experiencing. A larger and wider evaluation of this 
intervention is required to establish the whether these signals manifest as meaningful change 
but are a promising start. 
Limitations  
The wider conclusions that can be drawn from both studies are limited by the size of the 
sample, although in the pilot intervention study encouraging signals were detected in the data 
and useful feedback was received. The sample had lower working memory scores and 
functioning levels than studies focusing on similar research questions, perhaps due to the high 
number of inpatient participants. However, the inclusion of these participants improved the 
generalisability compared to other studies. The lack of a non-clinical control sample prevents 
definitive conclusions to be drawn from Study 1 regarding autobiographical memory deficits in 
people with non-affective psychosis and within-group analyses were conducted.  
The scores in the intervention study, particularly for motivation, self-efficacy and anticipatory 
pleasure, were high for many participants at the pre-intervention stage. This left little room for 
movement on these scales, particularly improvement, and perhaps could be differently 
operationalised to try to manage this. However, the consistency across participants suggests 
this may be a feature of responding in this group and additional scales may be needed to 
detect meaningful changes. It is important to note that the guided recall condition had higher 
levels of negative symptoms prior to the intervention and this may have impacted on the 
findings. The intervention study took place in one session and there was no follow-up to assess 
the impact on functioning or the activities discussed – this would be important to include in a 






Clinical Implications  
This study adds support to the importance of using negative symptom measures which report 
expressive and experiential subscales (Messinger et al., 2011). These scales capture important 
heterogeneity in people with non-affective psychosis and, as in this study, the two clusters of 
symptoms relate differently to other constructs. This project, as discussed previously, adds 
important evidence to the existing body which demonstrates intact emotional experience in 
people with psychosis (Yan et al., 2012). This does not support the construct of “anhedonia” as 
described in depression existing in this group. There was also no evidence for the anticipatory 
pleasure deficit hypothesis in the ratings provided in the intervention study. Clinicians can rely 
on the emotional experience of people with psychosis and should highlight this and use it in 
interventions provided. Clinicians can also be confident in using autobiographical memories in 
their clinical work – these can be generated be people with psychosis along with the expected 
emotional experiences. The participants found the link between their memories and their 
future goals a useful idea to consider in the intervention and were able to engage with these 
ideas successfully. Initial signs for using additional memory prompts are encouraging and 
clinicians, across disciplines, could consider incorporating this brief intervention into their 
approach when working towards goal-setting and increasing activity.   
This study has contributed to our understanding of the role of autobiographical memory in the 
difficulties experienced by people with psychosis. It is not the same link as in depression as the 
same relationship with these symptoms is not consistently present. Instead, links between 
autobiographical memory and expressive symptoms, functioning and self-defeatist beliefs may 
be relevant for future clinical research. Interventions targeting negative symptoms are in the 
early stages of development and this study has highlighted that guided recall of positive 
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Participating NHS Organisations in England  
This provides detail on the types of participating NHS organisations in the study and a statement 
as to whether the activities at all organisations are the same or different.   
This study will involve a single NHS organisation where research activities will take place as per 
protocol.  
  
If this study is subsequently extended to other NHS organisation(s) in England, an amendment 
should be submitted to the HRA, with a Statement of Activities and Schedule of Events for the 
newly participating NHS organisation(s) in England.   
  
The Chief Investigator or sponsor should share relevant study documents with participating 
NHS organisations in England in order to put arrangements in place to deliver the study. The 
documents should be sent to both the local study team, where applicable, and the office 
providing the research management function at the participating organisation. For NIHR CRN 
Portfolio studies, the Local LCRN contact should also be copied into this correspondence.  For 
further guidance on working with participating NHS organisations please see the HRA website.  
  
If chief investigators, sponsors or principal investigators are asked to complete site level forms 
for participating NHS organisations in England which are not provided in IRAS or on the HRA 
website, the chief investigator, sponsor or principal investigator should notify the HRA 
immediately at hra.approval@nhs.net. The HRA will work with these organisations to achieve a 
consistent approach to information provision.   
  
Confirmation of Capacity and Capability   
This describes whether formal confirmation of capacity and capability is expected from 






This is a single site study co-sponsored by the site. The R&D office will confirm to the CI when 




Principal Investigator Suitability  
This confirms whether the sponsor position on whether a PI, LC or neither should be in place is 
correct for each type of participating NHS organisation in England and the minimum 
expectations for education, training and experience that PIs should meet (where applicable).  
A local collaborator would be needed at site to facilitate the access of externally employed 
researchers.   
  
The sponsor should confirm to site any training expectations that they have.  
  
GCP training is not a generic training expectation, in line with the HRA statement on training 
expectations.  
  
HR Good Practice Resource Pack Expectations  
This confirms the HR Good Practice Resource Pack expectations for the study and the pre-
engagement checks that should and should not be undertaken  
A researcher requiring access to the NHS site to carry out the research activities, who does not 
have an existing contractual arrangement, would be expected to obtain a Letter of Access.  This 
would be based on standard DBS checks and occupational health clearance.   
  
  
Other Information to Aid Study Set-up   
This details any other information that may be helpful to sponsors and participating NHS 
organisations in England to aid study set-up.  



















          
Is there a Relationship between Memory for Past Events and 
Motivation for Future Activities? 
 
 
PARTICIPANT INFORMATION SHEET 
 
 
You are being invited to take part in a research project.  Before you decide it is 
important for you to understand why the research is being done and what it will 
involve.  Please take time to read the following information carefully. Talk to 
others about the project if you wish.  
 
Ask a member of the research team if there is anything that is not clear or if you 





• This project is for people with a diagnosis of psychosis who find it difficult to get 
motivated or have the energy to do things in life.   
 
• The aim of the project is to investigate whether problems with memory for past 
events are linked to difficulties with motivation, and whether completing a 
memory task impacts on people’s motivation to do things in the future.  
 
• The project involves 2 parts. In the first part, you will be asked to remember two 
events from your past and will be supported to answer questions about 







• In the second part a third of people will recall memories in the same way as the 
first part of the project. The remaining two thirds will be given additional support 
in recollecting these memories to see if this has any impact on motivation. 
 
• Whether you get the additional support with recalling memories will be decided 
randomly by a computer, like tossing a coin. 
 
• Your usual care will not be affected whether or not you decide to take part.  
 
What is the aim of the project? 
Difficulties with motivation (or feeling willing and able to do things) are common.  This 
has a negative effect on people’s lives, as they may not do the things they want.  
Research suggests that people under the care of mental health services view improving 
these difficulties as an important part of their recovery. However, no existing therapies 
have been shown to be effective in helping with motivation problems alongside 
psychosis, and psychological interventions need to be developed.   
Research suggests that memories of past events may impact on our motivation to do 
things in the future. However, we do not fully understand how recalling the past impacts 
on motivation. This project aims to find out how remembering previous events is related 
to people’s difficulties, and whether a task supporting memory recollections has any 
impact on motivation.  It is anticipated that the findings of this project may help in 
developing new therapies for people who are experiencing difficulties with motivation.  
Who can take part? 
This project is for people with a diagnosis of psychosis who are experiencing problems 
with enjoying activities, low motivation and low energy levels. The researcher will 
discuss these things with you when you first meet to see if you are suitable to take part.  
Do I have to take part? 
No. It is up to you to decide whether or not to take part. If you do, you will be 
given this information sheet to keep and be asked to sign a consent form. You 
are still free to withdraw at any time and without giving a reason. A decision to 
withdraw at any time, or a decision not to take part, will not affect the care you 
receive.  
 
What will happen if I take part? 
You will be asked to complete a memory task. This memory task will involve you 
recalling two memories from your past, you will be able to choose the ones you share 
and we will audio record what you describe. These recordings will be anonymised and 
will be listened to only by other members of the research team. The memory task 
should take no more than 45mins.  
 
During the session we will also support you to answer some questions about yourself 






experiences. The entire session will last approximately 2 hours; this can be broken 
down into more sessions if this is more convenient for you.  
 
The second stage of the project is shorter, and should only last for 1 hour at the most. It 
is entirely up to you whether you wish to do the second part of the project and you will 
be asked if you would like to at the end of the first part of the project. If you decide you 
do want to take part the researcher will consider with you the most convenient time to 
schedule this session. This second part should take place within 4 weeks of the first 
stage of the project. If you only wish to take part in the first stage of the project your 
participation will end at this point.   
 
If you decide to take part, you will be randomly allocated to take part in one of two 
pathways. Everyone will be asked to recall two positive memories about an activity that 
could happen again (e.g. going shopping, seeing a friend). In one pathway this will be 
done the same way as in the first part of the project, and in the other additional support 
will be given when recalling the memory. You will then be asked some questions about 
how you feel about the activities, before and after recalling the memories.  We can then 
compare the two groups to see if the additional support had any impact on motivation.   
Expenses and Payments 
If you decide to participate in the first half of this project you will receive a reimbursement of 
£15 for your time. For the second stage of the project, you will receive an additional 
reimbursement of £10 for your time. These can be provided as vouchers if that is preferable to 
you.  
Unfortunately travel expenses cannot be provided in the funding of this project, however if this 
is a barrier to your participation the researcher will try to meet you somewhere that minimises 
the cost of travel.  
What are the possible benefits of taking part? 
This research hopes to develop our understanding of how we can best support people who are 
experiencing reduced pleasure and motivation. This will hopefully contribute to the 
development of new therapies to improve people’s quality of life. There will be no immediate 
benefits from taking part but there will hopefully be long-term benefits for individuals with 
similar difficulties.  
What will happen if I don’t want to carry on with the project? 
The decision about whether to take part in the project is entirely your own. You can 
decide not to take part or withdraw from the project at any time, without having to give a 
reason, and this will not affect your care in any way.  
If you do decide to withdraw, we will keep the data we have already collected from you, 
but you will not have to take part further in the project. You can also request for any 
data collected to be destroyed. The same will apply if for any reason you are no longer 







What if there is a problem? 
If you have a concern about any aspect of this project, you should ask to speak with the 
researcher who will do their best to answer your questions or you can talk to the project 
supervisor Dr Amy Hardy (0207 848 5178). If you become distressed or unwell at any 
point during the project then the session will stop and any data collected up until that 
point will be used in the analysis.  
 
Should you wish to make a formal complaint the contact details are as follows:  
Dr Gill Dale, Director of Research Quality; 
Head, Joint R&D Office of South London and Maudsley NHS Foundation Trust and 
Institute of Psychiatry, Psychology & Neuroscience (IoPPN), 
POO5, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), 
King's College London, De Crespigny Park, London SE5 8AF 
gill.dale@kcl.ac.uk.  
Will my taking part in this project be kept confidential? 
If you join the project, some parts of your medical records and the data collected 
for the project will be looked at by members of the research team, who will be 
authorised persons from the Institute of Psychiatry, Psychology & Neuroscience.  
They will have a duty of confidentiality to you as a research participant and 
nothing that could reveal your identity will be disclosed outside the research site.  
 
All information which is collected about you during the course of the research will be 
kept strictly confidential. At the beginning of the project, you will be allocated a number 
which will be used to identify all information we keep about you. Your name and 
address and will be kept in a separate place so that it will not be possible to identify any 
data stored about you.  All data will be collected directly from you or from your case 
notes. Only researchers involved in the project will have access to this data, although 
they will tell your care team that you are taking part in the project so they can support 
you with your participation. In accordance with safeguarding procedures, they will also 
inform your care team should there be any concern that you may pose a risk to yourself 
or others. The data will be stored for 7 years and then disposed of securely.  
 
The procedures for handling, processing, storage and destruction of their data 
are compliant with the Data Protection Act 1998. 
 
What will happen to the results of the research project? 
When the project is completed, the results will be written up for publication in academic 
journals and will be presented at scientific conferences. We will also produce a newsletter 
summarising the findings of the project which we will send to you and your clinical team. You 






Who is organising and funding the research?   
The project is organised by the Institute of Psychiatry, Psychology & Neuroscience, 
King’s College London. It is part of a Doctoral thesis in Clinical Psychology.   
Who has reviewed the project?  
All research in the NHS is looked at by an independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
and given favourable opinion by Camberwell St Giles Research Ethics Committee. 
 
Thank you for considering taking part in the project. Please keep a copy of 
this information sheet. You will also be given a copy of the consent form 
should you decide to sign it.  
 

































Version  7 
IRAS: 214063    CONSENT FORM   
 02/03/2017 
 
Is there a Relationship between Memory for Past Events and Motivation for 
Future Activities? 
 
Name of Researcher:   
                   Please initial box 
 
1. I confirm that I have read and understand the information sheet dated 02/03/2017 for 
the above project. I have had the opportunity to consider the information and ask 
questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical care or legal rights being affected.  
 
3. If for any reason the project is terminated early I understand any data collected up to 
that point will be included in the project unless I request for it to be withdrawn in which 
case it will be destroyed.  
 
4. I give permission for the researcher to inform my care team that I am taking part in the 
project and provide information relevant to my care. I understand that my participation 
in the project will be recorded in my electronic notes.   
 
5. I understand that relevant sections of any of my electronic notes and data collected during 
the project may be looked at by the researcher on the project. I give permission for these 









6. I give permission for the research to audio record my memory narratives in order to 
fully capture the detail in the description of my memories.  
 
7. I give permission for anonymized quotations from these audio recordings to be included 
in future publications (this is optional).  
 
8. I agree to take part in the above project.  
  
_______________ _______ ____________ 
Name of Participant Date Signature 
 
I have explained the project to the participant and have answered their questions honestly and 
fully. 
 
________________________ _____________ _______________ 





















Study 1 Test Battery  
 
Is there a Relationship between 
Memory for Past Events and Motivation 
for Future Activities? 
Baseline Data  
 
Measure Completed  Initials 
Personal Details   
AMT   




BDI   
DAS   
SAPS   
CAINS   
Time Use Survey   
Receipt   
 
























5. Marital Status 
 
 1. Single 
 2. Married 
 3. Divorced 
 4. Widowed 
 
 
6.  Country of origin 
     
1. UK 
2. West Indies 
3. India and Asia 
4. Africa 















7. Present Accommodation 
 
1.   Living with partner 
2. Living with parent or relative 
3. Living alone, or sharing house, flat 
                     4.     Living alone in lodgings (where some meals/laundry are provided) 
       5.   Supervised hostel or reception centre 
       6.   Hospital inpatient 
    
8.  Number of biological children 
 
 
9.   Current job status 
 
1.   None (includes housewife with no domestic responsibilities) 
2. Unskilled 
3. Semi-Skilled 
            4. Skilled 
       5.   Housewife with domestic responsibility e.g. child, infirm, aged relative 
 
12.  Highest Education Level Achieved 
  1. Primary School 
  2. Secondary School 
  3. Further Education 












13.   Latest diagnosis 
 
 
14.   Number of hospital admissions in the past 2 years 
 
 
15.   Alcohol use  
 
1.   None 
2. Once a month 
3. Once a week 
      4. More than once a week 
 
16.   Drug use  
 
1.   None 
2. Once a month 
3. Once a week 
      4. More than once a week 
 





















19. Medication Currently Taken.  
 
Name of Medication Dose Frequency Depot Y/N 
    
    
    
    






























Autobiographical Memory Test  
Instructions:  
“Please think about a specific event in the past that occurred at a particular time and 
place and lasted no longer than 1 day.”  
“As a practice please tell me about a specific time in the past when you listened to 
music or the radio.”  
Feedback: Either “Exactly, now do the same for the rest of the narratives.” Or “Good, 
but for the rest of the task please tell me about an event that occurred at a specific 
time or place.” 
[RECORD] 
“Picture a specific time in the past when a negative event occurred. Tell me about it in 


























Please rate the memory you have just recalled by placing an ‘X’ on the following scales: 
 
The number of visual details: 
 
0            50      100 
|__________|__________|__________|__________| 
                          None                                                                           A lot 
 
The number of sounds: 
 
0            50      100 
|__________|__________|__________|__________| 
 
None                                                                        A lot 
 
The number of smells and/or tastes: 
 
0            50      100 
|__________|__________|__________|__________| 
 
None                                                                         A lot 
 
How clear was the location? 
 
0            50      100 
|__________|__________|__________|__________| 
 







How clear was the arrangement of objects? 
 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all clear                                                           Very Clear 
 
 
How clear was the arrangement of people? 
 
 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all clear                                                           Very Clear 
 
 
How clear was the time of day? 
 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all clear                                                           Very Clear 
 
 
How positive were the emotions in the memory? 
 
0            50      100 
|__________|__________|__________|__________| 
 








“Picture a specific time in the past when a positive event occurred. Tell me about it in 








How negative were the emotions in the memory? 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all                                                                      Very Negative 
 
How intense were the emotions in the memory? 
 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all                                                                      Very Intense  
 
 
How much did you feel you were reliving the event? 
 
0            50      100 
|__________|__________|__________|__________| 
 










Please rate the memory you have just recalled by placing an ‘X’ on the following scales: 
 
The number of visual details: 
 
0            50      100 
|__________|__________|__________|__________| 
 
                          None                                                                           A lot 
 
The number of sounds: 
 
0            50      100 
|__________|__________|__________|__________| 
None                                                                        A lot 
 
The number of smells and/or tastes: 
 
0            50      100 
|__________|__________|__________|__________| 
 
None                                                                         A lot 
 
How clear was the location? 
 
0            50      100 
|__________|__________|__________|__________| 
 







How clear was the arrangement of objects? 
 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all clear                                                           Very Clear 
 
 
How clear was the arrangement of people? 
 
 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all clear                                                           Very Clear 
 
 
How clear was the time of day? 
 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all clear                                                           Very Clear 
 
 
How positive were the emotions in the memory? 
 
0            50      100 
|__________|__________|__________|__________| 
 
















How negative were the emotions in the memory? 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all                                                                      Very Negative 
 
 
How intense were the emotions in the memory? 
 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all                                                                      Very Intense  
 
 
How much did you feel you were reliving the event? 
 
0            50      100 
|__________|__________|__________|__________| 
 







Verbal Fluency Test  
 
Say “I’m going to give you a letter of the alphabet and I’d like you to generate as many 
words as you can beginning with that letter, but not names of people or places. For 
example, if I give you the letter “J” you could give me words like “jump, jam” and so on. 
But, you can’t give me words like Jack or Japan or use the same word and add to the 
end of it (e.g. Jump to jumping, jumped etc.) Do you understand? Are you ready? You 
have one minute. The letter I want you to use is the letter “F”.  
• Same again with the letter “A”.  









Say “We are now going to do exactly the same thing but this time with categories 
instead of letters. So, I am going to give you a category and I would like you to tell 
me as many words as you can that belong to that category, following the same 
rules as before. Do you understand? Are you ready? You have one minute. The first 
category is “animals”.  
• Same again with “vegetables”.  








Letter Number Sequencing 
I am going to say a group of numbers and letters.  After I say them, I want you to tell me the 
numbers first, in numerical order, starting with the lowest number.  Then tell me the letters in 









then the letter.  If I say 9 – C – 3, then your answer should be 3-9-C, the numbers in order first, 
then the letters in alphabetical order.   
Let’s practice.   F-6  (6-F) 
G-4  (4-G) 
3-W-5  (3-5-W) 
T-7-L  (7-L-T) 
1-J-A   (1-A-J) 
If the examinee makes an error on any Practice Item, correct her or him and repeat the 
instructions as necessary.  Even if the examinee fails all Practice Items, continue with the 
subtest. Do not repeat items. 
FAIL RULE: Test discontinued if all 3 trials of an item are missed. 























Instructions:   This questionnaire consists of 21 groups of statements. Please read each group 






then pick out the one statement in each group that best describes the way you have been 
feeling during the past two weeks, including today. Circle the number beside the statement 
you have picked. If several statements in the group seem to apply equally well, circle the 
highest number for that group. Be sure that you do not choose more than one statement for 






















       0       I do not feel sad. 
1 I feel sad much of the time. 
2 I am sad all the time. 




       0       I am not discourage about my future. 
1 I feel more discouraged about my future 
than I        
used to be. 
2 I do not expect things to work out for me. 
3 I feel my future is hopeless and will only 
get  
worse. 
3. Past Failure 
       0       I do not feel like a failure. 
1 I have failed more than I should have. 
2 As I look back, I see a lot of failures. 
3 I feel I am a total failure as a person. 
 
4. Loss of Pleasure 
       0       I get as much pleasure as I ever did from the 
                things I enjoy. 
1 I don’t enjoy things as much as I used to. 
2 I get very little pleasure from the things I 
used 
to enjoy. 
3 I can’t get any pleasure from the things I 
used 
to enjoy. 
5. Guilty Feelings 
       0       I don’t feel particularly guilty. 
1 I feel guilty over many things I have done 
or 
should have done. 
2 I feel quite guilty most of the time. 
3 I feel guilty all of the time. 
6. Punishment Feelings 
       0        I don’t feel I am being punished. 
1     I feel I may be punished. 
2     I expect to be punished. 
3     I feel I am being punished. 
 
7. Self-Dislike 
       0       I feel the same about myself as ever. 
1    I have lost confidence in myself. 
2    I am disappointed in myself. 
3    I dislike myself. 
 
8. Self-Criticalness 
       0       I don’t criticize or blame myself more than usual. 
1    I am more critical of myself than I used to be. 
2    I criticize myself for all of my faults. 
3    I blame myself for everything bad that happens. 
 
9. Suicidal Thoughts or Wishes 
       0       I don’t have any thoughts of killing myself. 
1    I have thoughts of killing myself, but I would 
not carry them out. 
       2       I would like to kill myself. 
       3       I would kill myself if I had the chance. 
 
10. Crying 
       0       I don’t cry anymore than I used to. 
       1    I cry more than I used to. 
2    I cry over every little thing. 
3    I feel like crying, but I can’t. 
11. Agitation 
0        I am no more restless or wound up than usual. 
1     I feel more restless or wound up than 
usual. 
2     I am so restless or agitated that it’s hard to 
stay 
still. 
3   I am so restless or agitated that I have to keep 
moving or doing something. 
12. Loss of Interest 
0       I have not lost interest in other people or 
    Activities 
1  I am less interested in other people or things        
than before. 
17. Irritability 
       0        I am no more irritable than usual. 
1 I am more irritable than usual. 
2 I am much more irritable than usual. 
3 I am irritable all the time. 
 
18. Changes in Appetite 
       0        I have not experienced any change in my 
    appetite. 
       1a     My appetite is somewhat less than usual. 
       1b     My appetite is somewhat greater than usual. 
       2a     My appetite is much less than before. 






































Instructions:  This inventory lists different attitudes or beliefs which people sometimes hold.  
Read EACH statement carefully and decide how much you agree or disagree with the 
statement.  For each of the attitudes, circle the number under the column that BEST DESCRIBES 
HOW YOU THINK.  Be sure to choose only one answer for each attitude.  Because people are 
different, there is no right answer or wrong answer to these statements.  To decide whether a 
given attitude is typical of your way of looking at things, simply keep in mind what you are like 




1. It is difficult to be happy unless one is good-looking, intelligent, rich and creative. 
 














2. People will probably think less of me if I make a mistake. 
 














3. If I do not do well all the time, people will not respect me. 
 





































5. If I do not do as well as other people, it means I am an inferior human being. 
 














6. If I fail at my work, then I am a failure as a person. 
 














7. If you cannot do something well, there is little point in doing it at all. 
 














8. Making mistakes is fine because I can learn from them. 
 



































10. If I fail partly, it is as bad as being a complete failure. 
 















11. If other people know what you are really like, they will think less of you. 
 















12. If I am to be a worthwhile person, I must be truly outstanding in one major respect. 
 





































14. If I ask a question, it makes me look inferior. 
 















15. I cannot trust other people because they might be cruel to me. 
 






























ID:  _________________________    DATE:  _________________   RATER:  
__________________ 
 
Overall Introduction:  In this interview, I’ll be asking you some questions about things 
you have been doing over the past week. In the first section, I’m going to ask you some 
questions about your family, romantic partners, and friends, including how motivated 
you have been to spend time with them and how you felt when you were around them. 
 
I. SOCIAL (MOTIVATION & PLEASURE)   
 
ITEM 1: MOTIVATION FOR CLOSE FAMILY/SPOUSE/PARTNER RELATIONSHIPS 
[Note: Romantic relationships can be rated in either Item 1 or Item 2 but NOT both. A 
spouse/ partner relationship in which the couple is living together should be assessed 
in Item 1. A dating/romantic relationship in which the couple is not living together should 
be assessed in Item 2.] 
 
The following questions are about your family. This can include relatives like parents, 
brothers or sisters and other relatives, as well as your spouse [if married] or live-in 
partner. Have you been in contact with or visited with any family members in the past 
week (in person, phone, email)?  Any contact with a spouse or partner? 
 
IF CONTACT: 
• Who have you been in contact with?  
• What things have you done with your family? 
• IF RELEVANT: What things have you done with your spouse/partner? 




• What have you done to see or contact your [family/spouse/partner] in the past week?  
• When you were with your [family/spouse/partner] who decided what you would do? 
• Who started the conversation? Did you start it? Did your [family/spouse/partner]? 
Were you involved in the conversation? 
• Did you ever find that you quickly wanted to end your interactions with your 
[family/spouse/partner]? Did you want them to last longer?  
 
 
Motivation & Interest in Closeness 
• Have you been motivated to be around or in touch with your [family/spouse/partner] in 
the past week? (Why is that?) 
• What did you talk about? Can you talk about good and bad times with your 
[family/spouse/partner]?  
• How close do you feel to your [family/spouse/partner]?  What does being close mean 
for you? 
• Were there times in the past week when you just didn’t want to be around or in touch 







• How important is being part of a family to you? 
•  What about that is important to you? Have you felt this way throughout the past 
week? 
 
IF NO FAMILY CONTACT: 
[NOTE:  This section applies when not part of a close family or if available relatives 
could be contacted but person has chosen not to interact. If the person is not currently 
in a relationship with a live-in spouse/partner, interest in romantic relationships is 
assessed in Item 2.] 
 
• Has your family tried to contact you or visit you in the last week?  
• Has anything kept you or held you back from being in contact with your family?  
• Do you wish you were closer to your family? OR Do you wish you were part of a close 
family?  
• Did you miss interacting with your family in the past week?  
• Is having a relationship with your family important to you?  What about having a 
relationship is important to you? 





































0 = No impairment: VERY INTERESTED in and highly values close family bonds 
as one of the most important parts of life. Strongly desires and is highly 
motivated to be in contact with family. Regularly initiates and persists in 
interactions with family and actively engages in these interactions; good and 
bad times are openly discussed. Well within normal limits. 
1 = Mild deficit: GENERALLY INTERESTED in and values close family bonds 
though response suggests some minor or questionable reduction. Generally 
desires and is motivated to maintain contact with family. Has a close 
relationship with family member(s) in which good and bad times can be 
discussed.  Mild deficit in initiating and persisting in regular interactions with 
family – generally actively engaged when interactions occur.  
2 = Moderate deficit: SOMEWHAT INTERESTED in family relationships and 
considers them somewhat important. May occasionally miss close connections 
with family but is only somewhat motivated to seek out interaction with family. 
Notable deficit in initiating and persistently engaging in interactions; discussion 
of good and bad times is limited. Interactions with family members may occur 
but are largely superficial and participation is best characterized as “going 
through the motions”; interactions are more likely initiated by family with mostly 
passive involvement of the person.  
3 = Moderately severe deficit: LITTLE INTEREST in family relationships (could 
“take it or leave it”) and does not describe family bonds as important. Describes 
hardly any motivation and minimal effort to have close family relationships. 
Rarely has discussion of good and bad times with family members. Contact and 
engagement with family is superficial and passive with almost all initiation and 
efforts to engage coming from others. 
4 = Severe deficit: NO INTEREST in family relationships and does not consider 
them at all important. Prefers to be alone and is not at all motivated to be with 
family. If person does see family, it is done so grudgingly, passively and with no 
interest. 
 
ITEM 2: MOTIVATION FOR CLOSE FRIENDSHIPS & ROMANTIC RELATIONSHIPS 
Let’s talk about friends (IF RELEVANT: and dating or romantic relationships) now. By 
friends, I mean people who you know and spend time with, anyone you consider a 
friend, or people you can rely on and count on. Have you had any contact with friends 
in the last week (in person, phone, email)?  IF RELEVANT: have you been in contact 
with a romantic partner or dating in the last week?   
 
IF CONTACT: 
• In the past week, what have you done with your [friends/partner/dates]? 















• When you were with your [friends/partner/dates], who decided what you would do? 
• When you spoke with your [friends/partner/dates], who started the conversation? Did 
you?  
• Did you ever find that you quickly wanted to end your interaction with your 
[friends/partner/dates]? Did you want them to last longer?  
 
Motivation & Interest in Closeness 
• Have you been motivated to be around your friends (partner/dates) in the past week? 
Why is that? 
• Can you talk about both good times and bad times? 
• Were there times in the past week when you just didn’t feel like being around your 
friends (partner/dates)? 
• How important is having friendships (partner/dates) to you? What about that is 
important to you?   





IF NO FRIENDS/ROMANTIC CONTACT: 
• Are you interested in having friends or dating? 
• Is having friendships [or being in a romantic relationship] important to you? If Yes, 
what about [specify friendships/romantic partner] is important?  
• Did you miss these types of relationships in the past week? 
• Would you like to have friends [or a romantic partner] with whom you could talk about 
good and bad times? 
• (If any indication of interest) Have you taken any steps to meet someone who might 
be a friend (or romantic partner)?  
• Has anything kept you or held you back from being in contact with your friends?  
• Would you prefer to have friendships [or a romantic relationship] or would you prefer 























0 = No impairment: VERY INTERESTED in and highly values friend/romantic 
relationships as one of the most important parts of life. Strongly desires and is 
very motivated to engage in friendships. Regularly initiates and persists in 
interactions with friends/partner and actively engages in these interactions; 
good and bad times are openly discussed. Well within normal limits.  
1 = Mild deficit: GENERALLY INTERESTED in and values friend/romantic 
relationships though response suggests some minor or questionable reduction. 
Generally desires and is motivated to engage in friendships. Has 
friendships/relationship in which good and bad times can be discussed though 
this may be less consistent. Mild deficit in initiating or persistently engaging 
during interactions with friends/partner. If no friends/relationship, misses 
friend/romantic relationships, is motivated to have friends/relationship, and 
makes efforts to seek out friends/relationship. 
2 = Moderate deficit: SOMEWHAT INTERESTED in friend/romantic relationships 
and considers them somewhat important. May occasionally miss close 
connections with friends/partner and is somewhat motivated to have 
friends/partner. Notable deficit in initiating and persistently engaging in 
interactions; discussion of good and bad times is limited. Interactions with 
friends/romantic partner may occur but are largely superficial and participation 
is best characterized as “going through the motions”; interactions are initiated 
by others with mostly passive involvement of the person. If no friend/romantic 
relationships, is only somewhat motivated to have friends/partner and rarely if 
ever seeks out friends/partner. 
3 = Moderately severe deficit: LITTLE INTEREST in friend/romantic relationships 
(could “take it or leave it”) and does not describe friends/partner as important. 
Describes hardly any motivation to have friendships, and would just as soon be 
alone. Contact and engagement with others is superficial and passive with 
almost all initiation and efforts to engage coming from others.  
4 = Severe deficit: NO INTEREST in friend/romantic relationships and does not 
consider them at all important. Prefers to be alone and is not at all motivated to 
have friends/partner. 
 
ITEM 3: FREQUENCY OF PLEASURABLE SOCIAL ACTIVITIES – PAST WEEK  
[NOTE:  Ratings are based on NUMBER OF DAYS IN THE WEEK that pleasurable 
activity with other people is experienced. When there are reports of several different 
activities occurring, clarify if these happened on same or different days.] 
Now, I want to talk to you about how you felt during the times you spent with or were in 
contact with others during the past week. You can include times with any of the people 
we have talked about so far or anyone else.  Did you have any enjoyable interactions 
with other people, such as: 
• Family (PAUSE) 
• Romantic or dating partners (PAUSE) 
• Friends (PAUSE) 













• How many days did you enjoy/get pleasure from these interactions [time spent with xx 
person(s)] (for each)? 
• [If many (i.e., 5 or 6) days mentioned or if not clear which days of week interactions 





Item 3 – Frequency of Pleasurable Social Activities – Past Week 
 
0 = No impairment: Pleasure experienced daily. 
1 = Mild deficit: Pleasure experienced 5-6 days. 
2 = Moderate deficit: Pleasure experienced 3-4 days.  
3 = Moderately severe deficit: Pleasure experienced 1-2 days.  
4 = Severe deficit: No pleasure reported 
 
 
ITEM 4: FREQUENCY OF EXPECTED PLEASURE FROM SOCIAL ACTIVITIES – NEXT WEEK 
[NOTE:  Ratings are based on total NUMBER OF EXPECTED PLEASURABLE 
ACTIVITIES, regardless of days on which they are expected to occur]. 
 
Now I would like you to think ahead to NEXT week (next 7 days); thinking about whom 
you will spend time with. You can include people you have already talked about or 
anyone else. What do you think you will enjoy doing in the NEXT week with other 
people, such as your family (PAUSE), romantic partners (PAUSE), friends (IF 
NEEDED: people brought up in other sections)? 
 
IF ANSWERS PROVIDED: 
• What about it do you expect to enjoy?  
• How often do you think you will enjoy this in the next week?  
 
FOLLOW UP 
• Are there other experiences with people you think you will enjoy in the next week? 
 
 
ITEM 4 – Frequency of Expected Pleasure from Social Activities – Next week  
 
0 = No impairment: Expecting MANY (7 or more) pleasurable experiences. 
1 = Mild deficit: Expecting enjoyment from SEVERAL (5-6) pleasurable experiences. 
2 = Moderate deficit: Expecting enjoyment from a FEW (3-4) pleasurable 
experiences.  
3 = Moderately severe deficit: Expecting a COUPLE (1-2) pleasurable experiences. 
4 = Severe deficit: Expecting NO pleasurable experiences. 
 








ITEM 5: MOTIVATION FOR WORK & SCHOOL ACTIVITIES 
Now I am going to ask you some questions about work and school, including how 
motivated you have been for work or school activities and how you felt while doing 
these things over the past week. Have you been working or going to school over the 
past week?  Any volunteer work? Are you in a work-related treatment program?  
IF IN A RELEVANT ROLE: 
• Tell me about what you do in your [insert role here] 
• How much time has this involved over the past week? 
 
Behavior 
• Have you been able to complete tasks at [insert role here]?  
• In the past week has anyone raised any concerns with your [insert role here] 
performance? 
• Have you missed any days in the past week? Why? 
• Does someone need to remind you about [insert role here]? Why is that?  
• Were there things you meant to do or were supposed to do but just never got around 
to doing them? Why? 
 
Motivation  
• How do you feel about [insert role here]?  
• Have you been motivated to do your [insert role here]?  
• What motivates you to do your [insert role here]?   
• Were there times during the past week when you just didn’t feel like [insert role here]?  
• How important is your [insert role here] to you? What about it is important?  
 
IF NO CURRENT ROLE: 
• Is there a reason why you are not currently (work/school/volunteer)? 
• Has anything held you back from looking for (work/school/volunteer)? 
• How do you feel about working or going to school or volunteering? 
• Have you felt much interest in work/school/volunteer? (Tell me more) 
• Is working important to you? What about working/going to school/volunteering is 
important?   
• Do you miss work/school/volunteer? 
• Have you tried to take any steps to start working/going to school/volunteering? What 
















ITEM 5 – Motivation for Work & School Activities 
 
0 = No impairment: Person is VERY MOTIVATED to seek out work or school, or 
new opportunities in work or school; initiates and persists in work, school, or job-
seeking on a regular basis. Well within normal limits. 
1 = Mild deficit: Person is GENERALLY MOTIVATED to seek out work or school or 
new opportunities in work or school; a mild deficit in initiating and persisting; may 
report instances of initiating, but with moderate persistence.  
2= Moderate deficit: Person is SOMEWHAT MOTIVATED to seek out work or 
school or new opportunities in work or school; notable deficit in initiating; may 
have initiated activities, but needed reminders on multiple occasions, and/or not 
initiated any new activities, and/or not persisted for very long. 
3 = Moderately severe deficit: Person is only SLIGHTLY MOTIVATED to seek out 
work or school or new opportunities in work or school; significant deficit in 
initiating; may have needed constant reminders, and/or initiated a few activities; 
did not persist for very long.  
4 = Severe deficit: Person is NOT AT ALL MOTIVATED to seek out work / school; 
nearly total lack of initiation and persistence in work, school, or job seeking. 
 
 
ITEM 6: FREQUENCY OF EXPECTED PLEASURE FROM WORK & SCHOOL ACTIVITIES - NEXT 
WEEK  
[NOTE:  Ratings are based on total NUMBER OF EXPECTED PLEASURABLE 
ACTIVITIES, regardless of days on which they are expected to occur]. 
 
Now I would like you to think ahead to NEXT week (next 7 days); thinking about 
work/volunteer/school.  
 
IF HAS A RELEVANT ROLE:  
• What do you think you will enjoy doing in the NEXT week at work/volunteer/school, 
etc.  
 
IF NO RELEVANT ROLE:  
• Do you think you will enjoy anything related to seeking paid or volunteer work, or 
school?  
 
IF ANSWERS PROVIDED:  
• What about it do you expect to enjoy?  
• How often do you think you will enjoy this in the next week?  
 
FOLLOW UP: 











ITEM 6 – Frequency of Expected Pleasure from Work & School Activities – Next Week 
 
0 = No impairment: Expecting MANY (7 or more) pleasurable experiences. 
1 = Mild deficit: Expecting enjoyment from SEVERAL (5-6) pleasurable experiences. 
2 = Moderate deficit: Expecting enjoyment from a FEW (3-4) pleasurable 
experiences.  
3 = Moderately severe deficit: Expecting a COUPLE (1-2) pleasurable experiences. 




III. RECREATION (MOTIVATION & PLEASURE) 
 
 
ITEM 7: MOTIVATION FOR RECREATIONAL ACTIVITIES 
In the next section, I am going to ask you some questions about what you do in your 
free time – any hobbies or recreational activities. I will ask about your motivation and 
feelings about the things that you have done in your free time over the past week. 
 
• What have you done in your free time in the past week?  
• Have you participated in any hobbies or leisure activities such as sports or games, 
going to church, TV, music, reading, internet, walking or other such activities during 
the past week? 
 
IF YES:  
Behavior 
• Tell me about (activity). How much time has this involved over the past week? Did you 
want to do (activity) more than that?  Did it last longer than you had hoped? Why did 
it only last for (xx)? 




• How has your motivation or drive to get involved in these activities been over the past 
week?   
• Did you ever feel like you just weren’t very interested in these activities? 
• Are these types of activities important to you?  Why?  Have you been interested in 
these activities?  
• Did you ever feel that you would just as soon do nothing instead of getting involved in 










• Is there a reason why you haven’t gotten involved in any hobbies or recreational 
activities in the past week? 
• Have you wanted to or were you motivated to do something with your free time in the 
past? 
• Did anything ever get in the way of doing these types of activities over the past week?  





ITEM 7 – Motivation for Recreational Activities 
 
0 = No impairment: Person is VERY MOTIVATED to seek out hobbies and 
recreational activities; initiates and persists in hobbies and recreational activities 
on a regular basis, well within normal limits. 
1 = Mild deficit: Person is GENERALLY MOTIVATED to seek out hobbies and 
recreational activities; a mild deficit in initiating and persisting; may report initiating 
hobbies, but with moderate persistence.  
2 = Moderate deficit: Person is SOMEWHAT MOTIVATED to seek out hobbies and 
recreational activities; notable deficit in initiating; may have initiated some 
activities and/or not persisted for very long. Others were somewhat more likely to 
initiate hobbies or activities. 
3 = Moderately severe deficit: Person is only SLIGHTLY MOTIVATED to seek out 
hobbies and recreational activities; significant deficit in initiating and persisting; 
may have initiated a few activities and not persisted for very long. Others were 
much more likely to initiate hobbies or prompt initiation.  
4 = Severe deficit: Person is NOT AT ALL MOTIVATED to seek out hobbies and 




ITEM 8: FREQUENCY OF PLEASURABLE RECREATIONAL ACTIVITIES – PAST WEEK 
[NOTE: Rating is based on both VARIETY of pleasurable activities and DAILY 
FREQUENCY that these are experienced. When there are reports of several different 
activities occurring, need to clarify if these happened on same or different days.] 
 
Did you have any enjoyable (pleasurable) experience from things you did in your free 
time last week? You can include any of the activities we’ve talked about so far or any 
other leisure activities in the past week, including [use as needed] TV, sports or games, 
going to church, music, reading, internet, walking or other such activities?  
• What about [insert activity here] was enjoyable?   
• How many days did you enjoy/get pleasure from these experiences?  
 
FOLLOW UP:  











ITEM 8 – Frequency of Pleasurable Recreational Activities - Past Week 
 
0 = No impairment: At least A FEW (3) different types of pleasurable experiences, 
experienced daily. 
1 = Mild deficit:  At least A FEW (3) different types of pleasurable experiences, 
experienced more days than not.  
2 = Moderate deficit: 1 or 2 different types of pleasurable experiences, experienced 
more days than not.  
3 = Moderately severe deficit: 1 type of pleasurable experience, experienced on just 
a few days.  
4 = Severe deficit: No pleasurable experience 
 
ITEM 9: FREQUENCY OF EXPECTED PLEASURABLE RECREATIONAL ACTIVITIES – NEXT WEEK 
[NOTE:  Ratings are based on total NUMBER OF EXPECTED PLEASURABLE 
ACTIVITIES, regardless of days on which they are expected to occur] 
 
Now I would like you to think ahead to NEXT week (next 7 days); thinking about free 
time/hobbies/ recreation. What do you think you will enjoy doing in the NEXT WEEK in 
your recreational time [use as needed] such as sports or games, going to church, TV, 
music, reading, internet, walking or other such activities? 
• What about it do you expect to enjoy?  
• How often do you think you will enjoy  [activity] in the next week?  
 
FOLLOW UP: 
• Are there other things you do in your free time like hobbies or recreational activities 
that you think you will enjoy in the next week? 
 
 
ITEM 9 – Frequency of Expected Pleasure From Recreational Activities – Next Week 
 
0 = No impairment: Expecting MANY (7 or more) pleasurable experiences. 
1 = Mild deficit: Expecting enjoyment from SEVERAL (5-6) pleasurable experiences. 
2 = Moderate deficit: Expecting enjoyment from a FEW (3-4) pleasurable 
experiences.  
3 = Moderately severe deficit: Expecting a COUPLE (1-2) pleasurable experiences. 













ITEM 10: FACIAL EXPRESSION 
When making the facial expression rating, consider facial movements across all parts 
of the face, including in the eyes (e.g., raised brows), mouth (smiling or grimacing), and 




ITEM 10 - Facial Expression 
 
0 = No impairment: WITHIN NORMAL LIMITS; frequent expressions throughout the 
interview. 
1 = Mild deficit: MILD DECREASE in the frequency of facial expressions, with limited 
facial expressions during a few parts of the interview. 
2 = Moderate deficit: NOTABLE DECREASE in the frequency of facial expressions, 
with diminished facial expressions during several parts of the interview. 
3 = Moderately severe deficit: SIGNIFICANT LACK of facial expressions, with only 
a few changes in facial expression throughout most of the interview.  
4 = Severe deficit: NEARLY TOTAL LACK of facial expressions throughout the 
interview. 
 
ITEM 11: VOCAL EXPRESSION 
This item refers to prosodic features of the voice. This item reflects changes in tone 
during the course of speech. Speech rate, amount, or content of speech is not 
assessed.  
 
Item 11 - Vocal Expression 
 
0 = No impairment: WITHIN NORMAL LIMITS. Normal variation in vocal intonation 
across interview. Speech is expressive and animated. 
1 = Mild deficit: MILD DECREASE in vocal intonation. Variation in intonation occurs 
with a limited intonation during a few parts of the interview. 
2 = Moderate deficit: NOTABLE DECREASE in vocal intonation. Diminished 
intonation during several parts of the interview. Much of speech is lacking 
variability in intonation but prosodic changes occur in several parts of the 
interview. 
3 = Moderately severe deficit: SIGNIFICANT LACK of vocal intonation with only a 
few changes in intonation throughout most of the interview. Most of speech is flat 
and lacking variability, only isolated instance of prosodic change.  
4 = Severe deficit: NEARLY TOTAL LACK OF change in vocal intonation with 
















ITEM 12: EXPRESSIVE GESTURES 
Expressive gestures are used to emphasize what is communicated verbally through 
gestures made with the hands, head (nodding), shoulders (shrugging), and trunk 
(leaning forward, leaning back).  
 
ITEM - 12 Expressive Gestures 
 
0 = No impairment: WITHIN NORMAL LIMITS; uses frequent gestures throughout 
the interview. 
1 = Mild deficit: MILD DECREASE in the frequency of expressive gestures, with 
limited gestures in a few parts of the interview.  
2= Moderate deficit: NOTABLE DECREASE in the frequency of expressive 
gestures, with lack of gestures during several parts of the interview. 
3 = Moderately severe deficit: SIGNIFICANT LACK of expressive gestures, with 
only a few gestures throughout most of the interview.  




ITEM 13: QUANTITY OF SPEECH 
This item refers to the quantity of words spoken. Other speech abnormalities, such as 
disorganization, neologisms, or psychotic content are not rated here. For instance, a 
disorganized person may produce a large quantity of speech and have a low (normal) 
score on this item. 
 
 
ITEM - 13 Quantity of speech 
 
0 = No impairment: NORMAL AMOUNT of speech throughout the interview. Replies 
provide sufficient information with frequent spontaneous elaboration. 
1 = Mild deficit: MILD DECREASE in the quantity of speech, with brief responses 
during a few parts of the interview.  
2= Moderate deficit: NOTABLE DECREASE in speech output, with brief responses 
during several parts of the interview. 
3 = Moderately severe deficit: SIGNIFICANT LACK of speech, with very brief 
answers (only several words) in responses throughout most of the interview. 















(a) Did you do any paid work in the last month, either as an employee or self-employed?  
  
 YES      GO TO QU 4  
 NO      ASK b  
  
Have you been on a government scheme for employment training?     
 YES     DETAILS  
  
 NO    GO TO QU 2  
(a) Did you have a job or business you were away from?  
      
 YES    ASK b  
   NO     GO TO QU 3  
      
Why were you away? (Then ask QU 4 for typical work pattern when not away)  
      
Holiday     
Sickness    
Studying    
Maternity/paternity leave    
Other reason (please state)    
       
(a) Did you do any unpaid work for any business that you or a relative own?  
        
      YES     GO TO QU 4  








Have you ever had a paid job?   
        
      YES     ASK c & questions 4-7 for most recent paid job  
      NO    GO TO QU 8  
  
When did you leave your last paid job? 
 
What was your main job in the last month/most recent period of paid work?  
 





How many hours a week do you usually work in your main job or business?  Include any 
overtime.  How many hours have you worked in the last month?  
 
What was your take-home monthly pay after all deductions the last time you were paid?    
    
1  Less than £215      
2  £215 to less than £435    
3  £435 to less than £870     
4  £870 to less than £1305     
5  £1305 to less than £174     








7  £2820 to less than £3420    
8  £3420 to less than £3830    
9  £3830 to less than £4580    
10  £4580 to less than £6670    
11  £6670 or more      
  
In the last month, did you do any other paid work or have any other paid job or business,  in 
addition to the one you have just told me about?  
            
 YES     DETAILS (e.g. how many, number of hours, type of job, wages)  
 
  
   NO    IF NO PAID WORK AT ALL IN LAST MONTH, GO TO QU 8     
   IF CURRENTLY WORKING, GO TO QU 11  
  
Thinking of the last month, have you been looking for any kind of paid work government  
training schemes?  
        
      YES     ASK QU 9  
      NO    GO TO QU 10  
  
In the last month, did you do any of these things?  
                       
   
Visited a Jobcentre/Jobmarket or Training and Employment Agency Office?    
Visited a Jobclub?    
Had your name on the books of an employment agency?    
Advertised for jobs in newspapers, etc?    
Looked for advertisements in newspapers, etc?    
Answered advertisements in newspapers, etc?    






Asked friends, relatives, colleagues or trade unions about jobs?    
Waited for the results of a job application?    
Been to an interview?    
Done anything else to find work?  Please state.    
  




May I just check, what was the main reason you did not look for work in the last month?  
Waiting for the results of a job application/being assessed by training agent?    
Student?    
Looking after the family home?    
Temporarily sick or injured?    
Long-term sick or disabled?    
Believe no jobs available?    
Not yet started looking?    
Any other reason?  Please state.    
      
Are you at present receiving any state benefits in your own right or on behalf of anyone  in 
your household?  If so, which ones? (show list)  
 
EDUCATION AND TRAINING  
(a) Do you have any qualifications from school, college or university, connected with    
 work or from government schemes?  
  
 YES        ASK b onwards  
 NO        GO TO QU 2  
   Don’t know    GO TO QU 2    











Which qualification do you have, starting with the highest qualification (show list)?  
  
   
  
 
When did you last study for any qualifications?   
  
Are you studying for any qualifications at the moment (show list)?  
 YES        DETAILS (e.g. what, where, full/part time, hours, etc)  
          
  
1  Degree level qualification including graduate membership of a professional 
institute or PGCE or higher (include undergraduate and postgraduate degrees)  
  
2  Diploma in higher education                  
3  HNC/HND                      
4  ONC/OND                      
5  BTEC, BEC or TEC                  
6  SCOTVEC, SCOTEC or SCOTBEC                
7  Teaching qualification excluding PGCE               
8  Nursing or other medical qualification not yet mentioned?          
9  Other higher education qualification below degree level           
10  A-level or equivalent                    
11  SCE highers                      
12  NVQ/SVQ                      






14  AS-level                      
15  Certificate of sixth year studies (CSYS) or equivalent            
16  O-Level or equivalent                 
17  SCE Standard or Ordinary (O) grade                
18  GCSE                       
19  CSE                        
20  RSA                        
21  City and Guilds                    
22  YT certificate/YTP                    
23  
  
Any other professional or vocational qualification or foreign qualifications (e.g.   
apprenticeship)  
  
666  Don’t know                      
  




(a) In the last month, have you been on any taught courses or undertaken learning of any  
   of the following sorts:  
  
Taught courses meant to lead to qualifications (even if you did not obtain them)    
Taught courses designed to help you develop skills that you might use in a job    
Courses or instruction or tuition in driving, in playing a musical instrument, in an 
art or craft, in a sport or in any practical skill  
  
Evening classes             
Learning which involved working on your own from a package of materials 
provided     
  
  
IF YES TO ANY OF THE ABOVE ASK b   
IF NONE OF THE ABOVE GO TO QU 4       














   
 
 
 IF YES TO ANY OF THE ABOVE DETAILS (e.g. what, number of occasions in last month, 
length of time, etc)  




    IF NONE OF THE ABOVE      GO TO QU 6     
     
On how many occasions in the last month did you spend time studying at home outside of 
teaching sessions?   
  
How long did you study for the last time you did any?  How long on average do you normally 
study for?  
  
 
Thinking of the last month, have you been looking for any kind of education/course? 
Studied for a qualification without taking part in a taught course    
Received supervised training while you were actually doing a job        
Spent time keeping up-to-date with developments in the type of work you do without 
taking part in a taught course (e.g. by reading books, manuals journals, or attending 
seminars)  
  
Spent time deliberately trying to improve your knowledge about anything or teach 







YES  DETAILS (what, how much time, etc) 
 
NO GO TO VOLUNTARY WORK  
 
VOLUNTARY WORK  
Voluntary work is work that people may do for which they are not paid, except perhaps for 
expenses.  
Have you done any voluntary work through a group or on behalf of an organisation at any time 
during the last month?  
  
 
  NO        GO TO ‘LEISURE ACTIVITIES’  
 
How many different times did you do this work during the last month?  
 
 
How long did you work for, the last time you did this?  How long do you normally spend  doing 
this?  
 
LEISURE ACTIVITIES  
I am now going to ask some questions about things that some people do in their spare time.  
For each activity that I mention could you please tell me whether of not you have done this in 
the last month, AND how often?  
  
YES   
  










Been to cinema, film society or club      
Been to a sports event as a spectator      
Been to a play, musical or pantomime      
Been to the opera      
Been to a concert or performance of classical music of any 
kind  
    
Been to any other gig or live music performance (e.g. pop, 
rock or jazz concert, blues or folk club)  
    
Been to the ballet or to a modern/contemporary dance 
performance  
    
Been to a museum or art gallery      
Been to an historic house, castle or other heritage site or 
building  
    
Been to a library      
Been out to eat or drink at a café, restaurant, pub or wine 
bar  
    
Been to a shopping centre, or mall, apart from regular 
shopping for food and household items  
    
Been to a car boot sale, antiques fair or craft market or 
similar apart from regular shopping for food and 
household items  
    
Been to a theme park, fairground, fair or carnival      
Been to a zoo, wildlife reserve, aquarium or farm park      
Been to some other place of entertainment (e.g. dance, 
club, bingo, casino)  
    
Been on any other outdoor trips (including going to places 
of natural beauty, picnics, going for a drive or going to the 
beach)  
    
Other (please state)  
  
    
  
On these cards is a list of sports and physical activities.  Could you please tell me whether or 













Swimming or diving      
Cycling      
Indoor or outdoor bowls      
Tenpin bowling      
Keep fit, aerobics, yoga, dance exercise      
Martial arts      
Weight training or weight lifting      
Gymnastics      
Snooker, pool or billiards      
Darts      
Rugby      
Football      
Gaelic sports      
Cricket      
Hockey      
Netball      
Tennis      
Badminton      
Squash      
Basketball      
Table tennis      
Track and field athletics      
Jogging, cross country, road running      
Angling/fishing      
Yachting or dinghy sailing      
Canoeing      
Windsurfing/board sailing      
Ice-skating      
Curling      
Golf      
Skiing      
Horse riding      
Climbing/mountaineering      
Motor sports      






Walking or hiking for 2 miles or more (recreationally)      
Volleyball      
Other (please state)      
 
How much time do you spend socialising?  How many occasions in the last month have you 
seen friends, either visiting them or receiving visitors?  How much time did you tend to spend 
socialising on each occasion on average?  
 
How much time do you spend resting, i.e. taking time out and doing nothing (but not 
sleeping)?  How much time do you spend watching television or listening to the radio?  
Average for last month.  
 
HOBBIES  
Do you have any hobbies?  Show list of examples.  
    
  
  





















CHILD CARE  
  
Are you responsible for the care of any children?  
  
YES        ASK 2  
NO        GO TO ‘HOUSEWORK AND CHORES’  
 




How much time do you spend doing things with your children?  Ask individual to include 
checklist in their estimate (show card).  
 
  
HOUSEWORK AND CHORES  
  
How much time do you spend doing housework and chores per week?  Ask individual to 
include checklist in their estimate.  
  
Food management and preparation    
Cleaning, dusting, vacuuming, washing dishes    
Food shopping    
Washing    
Gardening    
DIY and repairs    



















OTHER ACTIVITIES  
  
How much time do you spend sleeping per day (on average)?  This includes sleep at night time 
and naps during the day.  Ask about good and bad days.  
 
  






















TIME USE INTERVIEW SCORE SHEET  
  
  
General Codings:  
  
0 = NO         1 = YES  




•  Is paid work in the last month present or absent?  
  
Present = ‘YES’ response to Question 1 (a), 1 (b), or Question 2  
  
    Absent = ‘NO’ response to Question 1 or 2  
  
NB.  ‘YES’ response to Question 3 (a) should be coded as voluntary work  
  




•  Salary band (Question 6)  
  
Code 1-11 or 666/999 (see interview)  
  
•  Hours per week in paid employment over the last month  
 
NB.  This should be calculated by adding all hours paid employment (from Questions 5 
and 7) 
 
and dividing by 4 to get a weekly average.  This includes time spent on 









 e.g. if someone generally gets one paid day of work per month, this is taken as 2 hours per  
  week  
    
•  Active searching for work?  
    
Present = ‘YES’ response to Question 8  
  
   Absent = ‘NO’ response to Question 8  
  
  
  Number of different work searching activities (taken from Question 9)  
  
  
•  Has paid work ever been present? (NB: Only code these items if no current paid work)  
  
Present = ‘YES’ response to Question 3 (b)  
  
 
   
 
 Number of hours per week worked in last       Number of weeks since last worked.  
 (Response to Question 3c)     (Response to Question 5)  
   
What was the last paid job? (Question 4)  
  
Salary band of your last job? (Question 6)  
       
     
























Highest level of educational qualification already achieved (Question 1b):  
  
  
Code 1-23 or 666/999 (see interview)  
  
Other educational or vocational qualifications already achieved (Question 1b):  
  
Enter codes:  
  
  
   
•  Is current education present or absent?  
  
Present = any ‘YES’ response to Questions 2, 3 or 4  
  
 Absent = ‘NO’ responses to Questions 2, 3 and 4  
  
Hours per week in education over the last month  
  
  
 NB.  This should be calculated by adding all hours spent in education (from Questions 2, 
3 4 and 5) and dividing by 4 to get a weekly average.    
  
  
•  Number of different courses taken part in over last month  
  














    
•  Active searching for education?  
    
Present = ‘YES’ response to Question 6  
  
 Absent = ‘NO’ response to Question 6  
  
 
VOLUNTARY WORK  
  
•  Is voluntary work present or absent?  
  
Present = ‘YES’ response to Question 1 or Question 3 (a) from Employment section  
  
 Absent = ‘NO’ response to Question 1   
  
•  Hours per week spent in voluntary work over the last month  
  
  
 NB.  This should be calculated by multiplying number of times (Question 2) by average 
length  of time (Question 3) and dividing the result by 4 to get a weekly average.  
  
LEISURE ACTIVITIES  
  
















•  Hours per week spent in leisure activities over the last month  
  
  
 NB.  This should be calculated by multiplying number of times by average length of time 
for  each activity.  Then sum all of these and divide the result by 4 to get a weekly 
average.  
  
•  Number of leisure activities taken part in over last month  
  
 NB.  Taken from Question 1    
  
 
•  Are sport/physical activities present or absent (taken from Question 2)  
 
  
•  Hours per week spent in sport/physical activities over the last month  
  
  
 NB.  This should be calculated by multiplying number of times by average length of time 
for  each activity.  Then sum all of these and divide the result by 4 to get a weekly 
average.  
  
•  Number of sport/physical activities taken part in over last month  
  
NB.  Taken from Question 2    
  
    














•  Are hobbies present or absent?  
 
  
•  Hours per week spent on hobbies over the last month  
  
  
 NB.  This should be calculated by multiplying number of times by average length of time 
for  each activity.  Then sum all of these and divide the result by 4 to get a weekly 
average.  
  
•  Number of hobbies taken part in over last month  
  
  
    
CHILDCARE  
•  Childcare    
  
 Applicable = 1  Non-applicable = 0      
 
•  Hours per week spent on childcare   
  







HOUSEWORK AND CHORES  
•  Hours per week spent on housework and chores   
  
  
 NB.  Taken from estimate of average time including items from checklist in estimate  
  
OTHER ACTIVITIES  
•  Hours spent per day sleeping (Question 1)  
 
 
•  Hours per week spent on other activities over the last month (Question 2)  
  
 NB.  This should be calculated by multiplying number of times by average length of time 
for each activity.  Then sum all of these and divide the result by 4 to get a weekly average.  
 

















Interviewer Autobiographical Memory Rating Scale  
 
1. Time/Place  
2 = inclusion of a time and 
place indicator 
1 = inclusion of a time or 
place indicator 
0 = omission of a specific 
time and place indicator 
   
 
2. Sociality  
2 = active engagement with 
others 
1 = passive (others present 
but no engagement) 
0 = alone 
   
 
3. Elaborative Detail  
2 = elaborated  1 = moderately elaborated 0 = general 
   
 
2 – elaborated – the narrative contained thorough and detailed descriptive information 
throughout.  
1 – moderately elaborated – the memory included somewhat expanded and detailed 
descriptive information in some but not all of the narrative.  
0 – general – the narrative was overly general and not very descriptive with respect to 
the essentials of the story.  
4. Clarity  
2 = clear 1 = moderately clear 0 = unclear 
   
 
2 – clear – organised and easy to understand  
1 – moderately clear – relatively understandable but at times the content was difficult 
to understand or follow.  







5. Emotional Content  
2 = a lot of emotional 
quality 
1 = some emotional quality 0 = no emotional quality 


































Similarly to the previous time we met you will be asked to recall two things which 
you’ve done, in today’s session we will only think about good or helpful things you’ve 
done.  
We’ll start off by selecting two things which you have done and I’ll ask you some 
questions about them.  Then we’ll watch a video to find out about why our memories 
for things we’ve done are important.  This will also talk about the most helpful ways of 
remembering things that have happened to us. 
We will then go through a memory you have of something that you’ve done together 
and I will ask you some questions to help you think about it in detail.  
After each thing you’ve done that you tell me about you will then be asked to complete 
a slightly longer questionnaire.   
Memory 1  
Instructions for Choosing a Positive Memory  
1) Something you remember quite clearly, maybe from the last year or so.  
2) The memory is of an event that did not last for more than one day.  
3) Something you think you might like, and be able, to do again. 
➔ Discuss memory choice with the person.  
Questionnaire 1- Pre 
1) Right now I feel [enthusiastic, satisfied, relaxed, cheerful] 0-10 
2) Right now I feel [down, guilty, anxious, annoyed] 0-10  
3) How likely is (specify behaviour or activity) to happen again? -10 (very unlikely)- 0 
(neither likely nor unlikely) – 10 (very likely). 
4) How able would you feel to do (specify behaviour or activity) in the future? 0 (not 
able at all) – 10 (very able) 
5) How enjoyable would (specify behaviour or activity) be if it were to happen again? (-
10 unpleasant -0 neutral -10 pleasant)  
Intervention  
Psychoeducation  
Video with pauses for discussion (see psychoeducation plan with script and prompts).  







- Hold your memory of the good or helpful thing you did in mind  
- Tell me about it as if you were telling a story  
- Try to include specific details: where, when, who was there.  
- Try to cover all 5 senses: sight, sounds, smells, touch, taste.  
- Remember ABC: Activity, Be Specific, Consider.  
Possible Additional Prompts  
- Elaboration  
o How did you feel? What emotions were you experiencing? [have 
emotion prompt sheet visible] 
o How did you feel in your body? 
 
- Generalisability  
o What is good or helpful about this thing that happened for you? 
o What does the fact that this happened say about you as a person? 
o What does this thing you’ve done tell you about what you like? 
o What does this thing you’ve done tell you about your strengths? 
o Does this thing that happened link to other things you’ve experienced? 
o What is similar about these experiences and this thing that happened?  
o What do these similarities tell us about you as a person? 
 
- Links to the future  
o Would you like to repeat this (specify behaviour or activity)?  
o Why?  What about it do you like? What about it matters to you? What 
did you enjoy about it at the time? 
o What would make it more likely that (specify behaviour or activity) will 
happen again in the future?  What could you do to help make it more 
likely?   
 
Questionnaire 2- Post  
1) Right now I feel [enthusiastic, satisfied, relaxed, cheerful] 0-10 
2) Right now I feel [down, guilty, anxious, annoyed] 0-10  
3) How likely is (specific behaviour or activity) to happen again? -10 (very unlikely)- 0 
(neither likely nor unlikely) – 10 (very likely). 
4) How able would you feel to do (specific behaviour or activity) in the future? 0 (not 
able at all) – 10 (very able) 
5) How enjoyable would (specific behaviour or activity) be if it were to happen again? (-






6) How pleasant was the memory of (specific behaviour or activity)? (-10 unpleasant -0 
neutral -10 pleasant) 
7) The memory of (specific behaviour or activity) felt real to me (0 not at all – 10 very 




Instructions for Choosing a Positive Memory  
1) Something you remember quite clearly, maybe from the last year or so.  
2) The memory is of an event that did not last for more than one day.  
3) Something you think you might like and be able to do again. 
➔ Discuss memory choice with the person.  
Questionnaire 3- Pre 
1) Right now I feel [enthusiastic, satisfied, relaxed, cheerful] 0-10 
2) Right now I feel [down, guilty, anxious, annoyed] 0-10  
3) How likely is (specify behaviour or activity) to happen again? -10 (very unlikely)- 0 
(neither likely nor unlikely) – 10 (very likely). 
4) How able would you feel to do (specify behaviour or activity) in the future? 0 (not 
able at all) – 10 (very able) 
5) How enjoyable would (specify behaviour or activity) be if it were to happen again? (-
10 unpleasant -0 neutral -10 pleasant)  
Intervention  
Guided Memory Recall  
Instructions  
- Hold your memory of the good or helpful thing you did in mind  
- Tell me about it as if you were telling a story  
- Try to include specific details: where, when, who was there.  
- Try to cover all 5 senses: sight, sounds, smells, touch, taste.  
- Remember ABC: Activity, Be Specific, Consider.  
 Possible Additional Prompts  
- Elaboration  
o How did you feel? What emotions were you experiencing? [have 
emotion prompt sheet visible] 







- Generalisability  
o What is good or helpful about this thing that happened for you? 
o What does the fact that this happened say about you as a person? 
o What does this thing you’ve done tell you about what you like? 
o What does this thing you’ve done tell you about your strengths? 
o Does this thing that happened link to other things you’ve experienced? 
o What is similar about these experiences and this thing that happened?  
o What do these similarities tell us about you as a person? 
 
- Links to the future  
o Would you like to repeat this (specify behaviour or activity)?  
o Why?  What about it do you like? What about it matters to you? What 
did you enjoy about it at the time? 
o What would make it more likely that (specify behaviour or activity) will 
happen again in the future?  What could you do to help make it more 
likely?   
Questionnaire 4- Post  
1) Right now I feel [enthusiastic, satisfied, relaxed, cheerful] 0-10 
2) Right now I feel [down, guilty, anxious, annoyed] 0-10  
3) How likely is (specific behaviour or activity) to happen again? -10 (very unlikely)- 0 
(neither likely nor unlikely) – 10 (very likely). 
4) How able would you feel to do (specific behaviour or activity) in the future? 0 (not 
able at all) – 10 (very able) 
5) How enjoyable would (specific behaviour or activity) be if it were to happen again? (-
10 unpleasant -0 neutral -10 pleasant)  
6) How pleasant was the memory of (specific behaviour or activity)? (-10 unpleasant -0 
neutral -10 pleasant) 
7) The memory of (specific behaviour or activity) felt real to me (0 not at all – 10 very 
much so).  
➔ Complete Feedback Questionnaire  
 







Is there a Relationship between 
Memory for Past Events and Motivation 
for Future Activities? 
 
Intervention Data  
 
Measure Completed  Initials 
Memory 1 Pre-   
Memory 1 Post-   
Memory 2 Pre-   










Memory 1 Pre- 











Memory Keyword:  
 
Right now I feel down 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So  
 
Right now I feel guilty 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So  
 
Right now I feel cheerful 
 
0            50      100 
|__________|__________|__________|__________| 
                         Not at all                                                                    Very Much So  
 
Right now I feel anxious 
 
0            50      100 
|__________|__________|__________|__________| 
 







Right now I feel satisfied 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
  
 
Right now I feel relaxed 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
 
 
Right now I feel annoyed 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
  
 
How likely do you think it is that ____________________ will happen again? 
 
0            50      100 
|__________|__________|__________|__________| 
 















How able do you feel to do ____________________ again in the future? 
 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all                                                                      Totally 
 
How enjoyable would _______________________ be if you were to do it again? 
 
0            50      100 
|__________|__________|__________|__________| 
 








Memory 1 Post- 
Memory Keyword:  
 
Right now I feel down 
 
0            50      100 
|__________|__________|__________|__________| 
                         Not at all                                                                    Very Much So  
 
Right now I feel guilty 
 
0            50      100 
|__________|__________|__________|__________| 
                         Not at all                                                                    Very Much So  
 
Right now I feel cheerful 
 
0            50      100 
|__________|__________|__________|__________| 
                         Not at all                                                                    Very Much So  
 
Right now I feel anxious 
 
0            50      100 
|__________|__________|__________|__________| 
 








Right now I feel satisfied 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
  
 
Right now I feel relaxed 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
 
 
Right now I feel annoyed 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
  
 
How likely do you think it is that ____________________ will happen again? 
 
0            50      100 
|__________|__________|__________|__________| 
 










How able do you feel to do ____________________ again in the future? 
 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all                                                                      Totally 
 
How enjoyable would _______________________ be if you were to do it again? 
 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all                                                                      Totally 
 
 
How pleasant was the memory? 
 
-10            0      10 
|__________|__________|__________|__________| 
 
Unpleasant                                                                   Pleasant 
 
 
The memory felt real to me 
 
0            50      100 
|__________|__________|__________|__________| 
 







Memory 2 Pre- 
Memory Keyword:  
 
Right now I feel down 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So  
 
Right now I feel guilty 
 
0            50      100 
|__________|__________|__________|__________| 
                         Not at all                                                                    Very Much So  
 
Right now I feel cheerful 
 
0            50      100 
|__________|__________|__________|__________| 
                         Not at all                                                                    Very Much So  
 
Right now I feel anxious 
 
0            50      100 
|__________|__________|__________|__________| 
 








Right now I feel satisfied 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
  
 
Right now I feel relaxed 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
 
 
Right now I feel annoyed 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
  
 
How likely do you think it is that ____________________ will happen again? 
 
0            50      100 
|__________|__________|__________|__________| 
 






















How able do you feel to do ____________________ again in the future? 
 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all                                                                      Totally 
 
How enjoyable would _______________________ be if you were to do it again? 
 
0            50      100 
|__________|__________|__________|__________| 
 






Memory 2 Post- 
Memory Keyword: 
 
Right now I feel down 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So  
 
Right now I feel guilty 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
 
Right now I feel cheerful 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So  
 
Right now I feel anxious 
 
0            50      100 
|__________|__________|__________|__________| 







Right now I feel satisfied 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
  
 
Right now I feel relaxed 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
 
 
Right now I feel annoyed 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
  
 
How likely do you think it is that ____________________ will happen again? 
 
0            50      100 
|__________|__________|__________|__________| 
 












How able do you feel to do ____________________ again in the future? 
 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all                                                                      Totally 
 
How enjoyable would _______________________ be if you were to do it again? 
 
0            50      100 
|__________|__________|__________|__________| 
 
Not at all                                                                      Totally 
 
 
How pleasant was the memory? 
 
-10            0      10 
|__________|__________|__________|__________| 
 
Unpleasant                                                                   Pleasant 
 
 
The memory felt real to me 
 
0            50      100 
|__________|__________|__________|__________| 
 






Memory Intervention Feedback Questionnaire 
 
 
Please complete the questions below which will ask you about your experience of the 
intervention. Please be honest and give us any ideas you think may benefit people who 
take part in something similar in the future.  
 
 
1. The session was helpful  
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
 
 
2. The session was easy to take part in 
 
0            50      100 
|__________|__________|__________|__________| 
                         Not at all                                                                    Very Much So 
 
3. I learned something from the session 
 
0            50      100 
|__________|__________|__________|__________| 
                         Not at all                                                                    Very Much So  
4. The session was relevant to my difficulties 
 
0            50      100 
|__________|__________|__________|__________| 
 






















5. I would recommend the session to others experiencing similar difficulties 
 
0            50      100 
|__________|__________|__________|__________| 
 
                         Not at all                                                                    Very Much So 
  
 
6. I would take part in something similar in the future 
 
0            50      100 
|__________|__________|__________|__________| 
 













______________________________   
 





______________________________   
 
 





______________________________   
 





______________________________   
 





______________________________   
 
 
 
 
 
